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Summary
Renal papillary necrosis (RPN) in man can follow abuse of non-narcotic 
analgesics or nonsteroidal anti-inflammatory drugs (NSAIDs).
Secondary cortical interstitial nephritis may also occur. Affected 
kidneys can progress to end-stage renal failure or urothelial carcinoma.
This study reports kidney lesions following administration of two 
oxicam NSAIDs, piroxicam (Feldene®, Pfizer) and CGP 13 214D to a non­
rodent species (baboon) as required by regulatory authorities for pre­
dictive toxicology.
Naturally-occurring kidney lesions were surveyed in 217 pairs of 
kidneys to provide data for comparison with treatment-related lesions. 
The ten most common changes comprised lymphocytic infiltrates (63%), 
multinucleate tubule cells (53%), altered glomeruli (46%), mineral­
isation (27%), urothelial inclusions (28%), urothelial vacuoles (20%), 
ectopic nephrons (16%), pyelitis (15%), tubular basophilia (11%) and 
tubulointerstitial nephritis (9%).
Treatment-related lesions included unilateral RPN in single animals at 
20 mg/ml and 6 mg/ml piroxicam, accompanied variously by epithelial 
hyperplasia, interstitial necrosis, haemorrhage, oedema and mineral­
isation. Calcium oxalate crystals were identified by histochemistry, 
scanning electronmicroscopy and X-ray diffraction methods. Similar 
changes without RPN were found with CGP 13 214D. Only urinalysis 
showed some indication of kidney damage during the study.
Data were compared with similar experimentally-induced NSAID lesions 
in other animals including man. Significant differences were noted.
- In this study RPN was focal, discrete, unilateral and less severe than
reported in man. No consistent cortical changes occurred. Crystals 
have not been reported in man, but were seen in this study. NSAID 
anti-prostaglandin activity is considered responsible for the kidney 
changes. Continued investigation into species variation of RPN, the 
regenerative capacity of medulla interstitial cells and improved non- 
invasive detection of renal function should contribute significantly 
to improved drug design for human clinical treatment.
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Chapter One 
Introduction
The kidneys are vital organs and are significant in their ability 
to reflect good health or disease. There is a considerable amount of 
research effort put into studies of normal and abnormal renal function 
in the general field of nephrology. Journals such as The Nephron,
Kidney International and Investigative Urology as well as specific 
textbooks devoted solely to the kidney confirm this. Within that 
diverse spectrum of investigation the more specialised field of nephro­
toxicity has emerged relatively recently, to study the effects of 
substances that selectively affect the kidney per se and cause distur­
bance of normal function. The emergence of this particular topic has, 
in turn, been indicated by the increasing number of articles in the 
published literature, and conferences of international stature allowing 
up-to-the-minute data to be quickly and widely communicated, and 
discussed. The study of nephrotoxicity is essentially multidisciplinary 
involving morphological, physiological, clinical, biochemical, patho­
logical and toxicological data, reflecting both the range of attitudes 
from which renal functions may be studied, and the complex cell types 
and cellular processes within the kidney (Bach, Bonner, Bridges and 
Lock, 1982). Nephrotoxicity in man can result from substances 
encountered in the industrial or social environment, and also from 
medicinal substances. A precise incidence of chemically-induced nephro­
toxic insult in the human population is impossible. Recognition of 
disturbed renal function is generally unreliable until most conditions 
are well advanced since the available criteria are either not 
sufficiently sensitive to detect early change, or are not sufficiently
specific to identify the particular affected cells within the kidney.
An improvement in some methodologies in recent years indicates the 
degree of importance attached to defining the fundamental aspects of 
renal change at the molecular level (Bach and Lock, 1984).
Toxic nephropathies identified in man have been attributed to a 
number of substances and include mercuric chloride, ethylene glycol 
(antifreeze), potassium chlorate; sulphonamides (Brod, 1982), amino­
glycoside antibiotics, cephalosporins (Fillastre, Kleinknecht, Godin, 
Viotte, Olier and Morin, 1982); mushrooms and other plants (Berndt, 
1982); radio-opaque materials (Mudge, 1982); heavy metals (Magos, 1982; 
Goyer, 1982; Bonner and Carter, 1982). Unfortunately, there are many 
more chemicals that have been inculcated in adverse renal function, and 
the numbers are increasing. This reflects the exposure of man through­
out his life to chemical substances that were intended to be beneficial 
but which nevertheless may be significantly detrimental to his well 
being. Analgesics were among the first agents of intended medical 
benefit to be identified as nephrotoxic (Zollinger and Spiihler, 1950) 
following prolonged intake over several years in quantities totalling 
kilograms. Results of such abuse of medication can today be detected 
clinically by radiological techniques to display altered pelvic calyceal 
and pyramidal morphology in the form of papillary necrosis. Patho­
logically the renal papillary necrosis (RPN) is often accompanied by 
chronic interstitial nephritis. The initial report from Switzerland 
was soon followed by similar findings in many other countries. Initial 
uncertainty in the pathogenesis was resolved (Burry, 1967) and it is 
now accepted that RPN is the primary lesion and the chronic 
inflammatory change in the cortex develops secondarily. Rheumatoid
arthritis is a widespread disease of the joints and is treated 
clinically not only with analgesics in an attempt to reduce the pain 
and discomfort, but also with anti-inflammatory drugs to reduce the 
cellular infiltrates. Those drugs with a nonsteroidal structure have 
also been involved in RPN in man when administered alone and in 
combination with analgesics. Renal papillary necrosis has been seen 
in man associated with renal transplantation (Edmondson, Fawcett,
Jones, Thompson and Wing, 1972), diabetes mellitus, sickle-cell nephro­
pathy, urinary tract obstruction, urinary tract infection and pyelo­
nephritis (Heptinstall, 1983), and chronic liver disease (Edmondson, 
Reynolds and Jacobson, 1966), in addition to chronic analgesic abuse.
In infancy and childhood RPN has been associated with perinatal stress, 
septicaemia, shock, diarrhoea and severe dehydration (Stirling, 1958; 
Mauer and Nogrady, 1969; Chrispin, Hull, Lillie and Ridson, 1970). The
majority of RPN in man however has been related to nonnarcotic anal­
gesic or nonsteroidal anti-inflammatory drugs.
Experimental administration of analgesics and nonsteroidal anti­
inflammatory drugs (NSAIDs) also produces RPN in some species of 
laboratory animal, the rat and the nonhuman primate. The current
interest in defining more efficient techniques for the detection of 
renal dysfunction will hopefully serve several purposes. They will 
contribute to a greater knowledge of the different cellular functions 
of the kidney and improved accuracy in detecting early change, and to 
developing animal models more closely relevant to man. Using such 
models should in turn allow more efficient chemical design of new 
medical entities together with an improved benefit to risk ratio in
treating kidney disease in man (Bach and Lotk, 1984). Current toxico- 
logical regulatory guidelines require new pharmaceutical compounds for 
intended use in man, to be tested for predictive toxicology in two 
species of laboratory animal, rodent and nonrodent. It is to the 
baboon as a nonhuman primate and as an example of a nonrodent species 
that this study is directed.
Nonhuman primates still occupy a valuable place in biomedical 
research since their introduction in the 1930's, when scientists 
realised their potential as models of some human diseases. Different 
species exhibit varying degrees of parallelism to irian. A considerable 
increase in the numbers used occurred in the 1950's with the successful 
production of the Salk poliomyelitis vaccine. Monkeys were used in 
several important fields of research such as epilepsy, malaria and the 
production and testing of vaccines, as well as in experimental surgery. 
They have also contributed significantly to kidney research and have 
been used in investigations into immune complex glomerulonephritis, 
schistosomiasis, leptospirosis, congenital malformations, hypospadia, 
hydronephrosis in pregnancy, vesicoureteral reflux, psychogenic poly­
uria and polydypsia, nephrocalcinosis, pyelonephritis and transplant 
surgery (Brack, McPhaul, Damian and Kalter, 1972; Voller, Davies and 
Hutt, 1973; Murphy and Grafton, 1973; Houba, 1979; Cornelius and 
Rosenberg, 1983). They are also utilised in predictive toxicology 
studies which include the detection of any nephrotoxic aspects of 
pharmaceutical compounds. Several different species of monkey have 
been used but the most popular single species has been the rhesus 
macaque (Macaca mulatta). Problems associated with both supply and 
disease focused attention on other alternative species including the
baboon (Papio spp.) in the early 1960's. Since that time the different 
species of baboon have shown their suitability in biomedical research 
in a variety of ways.
Baboons inhabit a very wide range of differing habitats in the 
wild. They are found mainly on the continent of Africa within an area 
that stretcher from the rain forests on the West coast to the very dry 
and arid regions on the East coast, and from the hot dry sub-Saharan 
fringe southwards to the Cape territories (Napier and Napier, 1967).
They also have a small presence on the Asian landmass in the region 
around Aden (Fig.l).
This enormous range of natural wild habitat has significant 
differences in geography and elimate which, in turn, are reflected in 
differences in diet and patterns of disease. Although some baboons are 
still caught in the wild there are significant numbers bred in special 
breeding centres, particularly in Texas in the United States of America 
and also at Sukhumi in the Crimean region of Russia. The two immediate 
and important advantages of animals produced under such controlled 
breeding programmes are the preservation of stock in the wild, and the 
improved health status of the specially bred animals themselves (Creamer, 
1966; Hackett, 1976; Kalter, 1980). In this way the most benefit 
can be derived from a valuable and basically irreplaceable animal 
resource (Osman Hill, 1969).
In the field of kidney research baboons as a species have been 
used in many important investigations covering a wide variety of 
relevant topics. They include studies on basic blood flow patterns 
(Stinson, 1971; Paton and Fisher, 1984; Gur, Jonas, Wolfson, Wozney, 
Colsher et al, 1984; Wozney, Gur, Yonas, Wolfson, Herbert et al, 1984),
Guinea baboon (Papio papio)
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Yellow baboon (Papio cynocephalus) 
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Figure 1: Distribution map of the various baboon species
(Napier and Napier, 1967)
the effects of prostaglandins on renal blood flow (Swain, Heyndrickx, 
Boettcher and Vatner, 1975); the effect of steroids (Coleman and 
Silbermann, 1980); glomerular changes in diabetes (Stout, Folse, Meier, 
Crosby, Kling et al, 1986); schistosomiasis (Brack et al, 1972); 
transplant surgery (Telander and Hitchcock, 1965; Murphy and Grafton, 
1973); physiology of hypertrophy (Dicker and Morris, 1972); renal 
function (Johnston, van Heerden, van Zyl, van Zyl, Retief and Murphy, 
1968) nephrocalcinosis (du Bruyn and Liebenberg, 1976), and many others. 
In the field of predictive toxicology they are used as an alternative 
animal species to rodents, as required by regulatory authorities, and 
as such may detect evidence of nephrotoxicity. This was recently demon­
strated by their inclusion in studies to detect the nephrotoxic effects 
of a haemoglobin tetramer where, other animal models had failed to 
predict the renal dysfunction noted in subsequent clinical trials in 
man (Moss, Gould, Rosen, Sehgal and Sehgal, 1986). It is clear there­
fore that the baboon has allowed the extraction of considerable and 
valuable data on the kidney, for use in man.
This study reports a range of toxicological responses by the 
kidney to certain nonsteroidal anti-inflammatory compounds (NSAIDs), 
and is presented in four parts. Firstly, by outlining the methods and 
materials used to obtain both control and experimental data in routine 
toxicological studies. Secondly, by describing the normal anatomy, 
histology and physiology of the baboon kidney. Thirdly, by describing 
the naturally-occurring pathological lesions that may be encountered 
in the kidneys of such wild-caught animals, maintained within the 
laboratory environment. Finally, in the fourth part by describing the 
lesions that may be seen after treatment with some NSAIDs, and comparing
and discussing them against reported effects of NSAIDs in other animals 
and man with particular reference to the mechanisms involved and 
reported in the literature.
Chapter 2 
Materials and Methods
Animal Sources
Baboons (Papio cynocephalus) of East African origin were obtained 
from an accredited supply agency for nonhuman primates (Shamrock Farms 
[Great Britain] Ltd., Victoria House, Small Dole, Henfield, Sussex,
BN5 9XE, UK).
All animals were quarantined for 2 months on the suppliers 
premises. During that time they were treated with anthelminthic drugs 
for intestinal parasites, examined and tested for the presence of 
tuberculosis by injection of mammalian tuberculin, and given clinical 
examinations prior to despatch.
General Management
Upon arrival in the unit animals were commonly within a weight 
range of 3 kg to 4 kg. Age was estimated by dental examination to be 
19 months to 24 months (Siegel and Sciully, 1973). They were individu­
ally housed and maintained in experimental areas for not less than two 
months prior to the start of the study. They were treated again for 
external parasites by the application of lindane powder (Coopers Animal 
Health) and for internal parasites using fenbendazole (Panacur, Hoechst) 
and niclosamide (Yomesan, Bayer). All animals were negative to a 
further tuberculin test using 1500 IU of mammalian PPD tuberculin 
intrapalpebrally, on at least one occasion.
The experimental quarters were consistently maintained at a 
temperature of 20 ± 2°C, and at a relative humidity of 65% to 75%. 
Artificial light was provided for 12 hours each day from 0700 to 1900 GMT. 
The animals were provided each day with 250 gm of a proprietary laboratory
diet for nonhuman primates (Mazuri Primate Diet [SQC] Special Diet 
Services Ltd., Witham, Essex, UK). Vitamin C was given orally as 
ascorbic acid tablets at 50 mg three times weekly, and tap water was 
freely available from individual automatic watering points. Each baboon 
was also given half an apple daily each morning following administration 
of the vehicle (control baboons) or the test compound (treated baboons).
Baboon data reported in this survey is divided into three sections 
The first deals with the anatomy, histology and physiology of the baboon 
kidney. The second with naturally-occurring background pathological 
lesions in the kidney and the third with pathological responses to treat 
ment with NSAIDs. Comments and results given in the first two sections 
were derived from control animals from a variety of different studies,
whilst those in the third section were made upon a particular study.
Nevertheless all baboon studies were subject to the same management 
procedures according to study protocols drawn up under Good Laboratory 
Practice (GLP) and in full awareness of the ethical and legal standards 
pertinent to such investigative work.
Clinical Examinations
A comprehensive management of all studies was performed from the 
pretest period to the terminal necropsies. All animals were observed 
frequently throughout the day for clinical signs. Faecal samples were 
taken weekly for detection of any occult blood. Body weights were
obtained weekly. Food consumption was measured daily. Blood samples
were taken under aseptic conditions from the femoral vein in the 
femoral triangle (Swindler and Wood, 1973). Samples were taken into 
heparinised tubes before each study commenced and at regular intervals 
throughout. The range of clinical chemistry and haematological assays
routinely performed are given in Tables 1 and 2. Urinalysis was 
performed at similar time intervals, upon 24 hour samples collected in 
a diuresis tray (Table 3). Routine faecal analysis was not performed. 
Specialist clinical examinations were made pretest and again at regular 
intervals throughout the study and comprised hearing and opthalmic tests. 
Hearing was tested by the animals reaction to the normal sounds of 
their environment. Ophthalmic examinations were made using a hand-held 
direct ophthalmoscope on animals sedated with phencyclidine 
hydrochloride, (Vetalar, Parke Davis), and with pupils dilated with 1% 
tropicamide (Mydriacyl, Abbott Laboratories).
Necropsy
At the termination of a study the animals were euthanised by 
intravenous administration of excess barbiturate (sodium pentobarbitone 
20% = 200 mg/ml, Nembutal, Abbott Laboratories). A thorough examination of 
the cadaver was made to include the general condition of the hair, all 
body orifices were examined and attention paid to the clinical in-life 
history and any clinical chemistry or haematological changes which had 
occurred during the course of the study. A complete necropsy comprised 
opening all major body cavities (cranial vault, thorax and abdomen), 
and examining their contents in situ. The contents were carefully 
removed, hollow viscera were incised and their inner surfaces 
scrutinised. Certain organs according to protocol were trimmed free 
of extraneous fat and connective tissue, weighed and data presented as 
absolute and relative values (Table 4). A comprehensive list of 
tissues and organs was sampled and fixed for subsequent histology 
(Table 5). The kidneys were weighed after trimming the vessels and 
ureter at the hilus and removing the capsule. Two transverse slices
ASSAY METHOD/INSTRUMENT UNITS
SODIUM/POTTASSIUM FLAME PHOTOMETER
[Corning 460 Operation Manual]
mmol/1
GLUCOSE COBAS BIO
[Barthelmai, W and Czok, R:
Klin. Wochenschr., 40, 585 (1962)]
mmol/1
UREA COBAS BIO
[Tiffany, T.O. et al:
Clin. Chem. 18, 829 (1972)]
mmol/1
ASPARTATE 
AMINOTRANSFERASE 
(ASAT)
COBAS BIO 
[Amador, E. et al:
Am. J. Clin. Path. 47, 419 (1967)]
U/l
at 37°C
ALAMINE
AMINOTRANSFERASE
(ALAT)
COBAS BIO
[Henry, R. J. et al:
Am. J. Clin. Path. 34, 381 (i960)]
U/l
at 37°C
ALKALINE 
PHOSPHATASE (AP)
COBAS BIO
[Anon: Z. Klin. Chem. und Klin. 
Biochem. 10, 182 (1972)]
U/l
at 37°C
TOTAL PROTEIN COBAS BIO
[Weichselbaum, T. E.
Am. J. Clin. Path. 16, 40 (1946)]
g/1
PROTEIN ELECTRO­
PHORESIS
CORNING SYSTEM, AGAROSE GEL 
[Corning Operation Manual]
% and 
g/1
Table 1: Clinical chemistry assays
ASSAY METHOD UNITS
HAEMOGLOBIN Ortho ELT 8 D/S g/dl
ERYTHROCYTES Ortho ELT 8 D/S x 1012/1
HAEMATOCRIT Ortho ELT 8 D/S 0.000
MEAN CORPUSCULAR 
VOLUME (MCV)
Derived fl
MEAN CORPUSCULAR 
HAEMOGLOBIN (MCH)
Derived Pg
MEAN CORPUSCULAR 
HAEMOGLOBIN 
CONCENTRATION 
(MCHC)
Derived g/dl
RETICULOCYTES 
AND INCLUSION 
BODIES
Unfixed smear stained with 1% 
Cresyl Violet
%
THROMBOCYTES Ortho ELT 8 D/S x 109/1
LEUCOCYTES
Total Ortho ELT 8 D/S x 109/1
Differential Blood smear stained with 
Leishman's stain
PROTHROMBIN
TIME
Quick One Stage Method 
Thromboplastin Boehringer
secs
ERYTHROCYTE 
SEDIMENTATION 
RATE (ESR)
Method of Westergren (200 mm tubes) mm
ANTICOAGULANTS Cellular Investigations EDTA 
Clotting Mechanisms and ESR 3.8% 
Sodium Citrate
Table 2: Haematology methods
ASSAY METHOD UNITS
SPECIFIC GRAVITY 
pH
PROTEIN
GLUCOSE
BILIRUBIN
UROBILINOGEN
KETONES
BLOOD
SEDIMENT
B M - Test - 8 (BC1
Refractometer (Atago)
B M - Test - 8 (BCL) 
Reference - B M Test Manual
B M - Test - 8 (BCL) 
Reference - B M Test Manual
B M - Test - 8 (BCL) 
Reference - B M Test Manual
B M - Test - 8 (BCL) 
Reference - B M Test Manual
B M - Test - 8 (BCL) 
Reference - B M Test Manual
B M - Test - 8 (BCL) 
Reference - B M Test Manual
B M - Test - 8 (BCL) 
Reference - B M Test Manual
Centrifuged deposit
3 000 rpm
for 10 minutes
L) is a dipstick method
1 = 0.3 g/1
2 = 1.0 g/1
3 = 5.0 g/1
1 = 5 . 6  mmol/1
2 = 16.7 mmol/1
3 = 55.5 mmol/1
1 = weakly positive
2 ■= moderately positive
3 = stongly positive
1 = 1 7  pmol/1
2 = 70 pmol/1
3 = 140 pmol/1
4 = 200 pmol/1
1 = 0.5 - 4.0 mmol/1
2 = 4.0 - 10.0 mmol/1
3 = > 10.0 mmol/1
1 = ca. 10 x 106 ery/1
2 = ca. 50 x 106 ery/1
3 = ca. 250 x 106 ery/1
1 = Trace
2 ^ Moderate
3 = Large
Table 3: Urinalysis methods
Adrenals
Brain
Heart
Kidneys
Liver
Ovaries
Pituitary
Spleen
Testes
Thymus
Thyroid
Percentage organ weights were calculated with reference 
to brain and body weights.
Organ Weight as a % brain weight = Organ Weight
Brain Weight X
Organ Weight as a % body weight = Organ Weight
T) J  r 7 . -I. X 100Body Weight
Table 4: Organs weighed at necropsy
Tissues/organs
Adrenals
Aorta
Bone Marrow (Sternum)
Brain
Eyes/Optic Nerves 
Gall Bladder 
Heart 
Kidneys
Large Intestine (Caecum, Colon)
Liver
Lungs
Lymph Nodes (Axillary, Mesenteric)
Oesophagus
Ovaries/Uterus/Mammary Area 
Pancreas
Peripheral Nerve 
Pituitary 
Salivary Gland 
Skeletal Muscle 
Skin
Small Intestine (Duodenum, Jejunum, Ileum) 
Spinal Cord (Cervical, Thoracic, Lumbar) 
Spleen 
Stomach
Testes/Epididymides/Prostate/Seminal vesicles 
Thymus
Thyroids/Parathyroids
Trachea
Urinary Bladder 
Gross lesions
Table 5: Tissues and organs sampled at necropsy
were taken at the level of the hilus, one into Bouin’s fluid, the other 
into buffered formalin. Photographs of significant gross lesions were 
taken using a Polaroid CU-5 Land camera (Fig.2).
Histology
At necropsy the brain and spinal cord were fixed in 10% neutral 
(pH 7.0) phosphate buffered formalin. Eyes and optic nerves were fixed 
in Davidson’s solution. All other tissues were fixed in Bouin's fluid 
and where possible a reserve set of samples was fixed in buffered 
formalin. Fixed tissue was embedded in paraffin wax (Tissue Tec 3, 
polymer added: Miles Laboratories Ltd,., PO Box 37, Stoke Poges, 
Slough). Brain and spinal cord sections were cut at 7p, bone-marrow at 
3p and all remaining sections were cut at 5p. Routine staining on all 
sections was done with haematoxylin and eosin (HE). Selected kidney 
sections from the same block were stained in addition by the following 
methods to highlight particular structures or changes (Tables 6 to 11). 
Photographs of lesions noted at trimming could also be taken using the 
Polaroid CU-5 Land camera (Fig.2) or a stereo dissection microscope 
camera (Fig.3).
Scanning electronmicroscopy (SEM):
Refractile particles, identified by light microscopy, were 
scraped off an unstained slide cut from the same paraffin block. The 
particles were floated out on to water, dried and mounted on double­
sided Sellotape on a copper stud. The specimen was dewaxed in xylene 
and coated with a thin layer of gold. Examination was performed in the 
scanning mode of a Jeol 100CX at 20KV and 40KV. X-ray diffraction 
microanalysis was performed in the microscope.
Position Automatic Procedures Stage Times
1 Xylene 3.00
2 Xylene 1.00
3 99 IMS 1.00
4 99 IMS .30
5 99 IMS .30
6 Deionised Water 1.00
7 Haematoxylin 1.30
8 Running Water 1.30
9 2% Phosphotungstic Acid in NaCl 2.30
10 2% Sodium Citrate 1.30
11 Deionised Water .30
12 99 IMS 1.00
13 2.5% Eosin in 99 IMS 1.00
14 99 IMS .20
15 99 IMS .15
16 99 IMS .15
17 Xylene/99 IMS (50:50) .55
18 Xylene 1.00
19 Xylene 1.00
20 Xylene 0.00
(IMS is industrial methylated spirits)
This procedure was performed using an automatic staining machine 
(Shandon 'Varistain' Type 242, Shandon Southern Products Ltd., Runcorn, 
Cheshire).
Table 6: Routine haematoxylin and eosin (HE)
Shorrs Stain Solutions
1 Harris's Haematoxylin
2 Shorr's stain
3 1% acid alcohol
Method
1 Slides to water
2 Stain in Harris's Haematoxylin 2 - 5  mins
3 Wash in running tap water
4 Differentiate in 1% acid alcohol
5 Blue in tap water
6 Stain in Shorr's stain 2 - 5  mins
7 Dehydrate in 70%, 90% then absolute alcohol, clear and mount 
Results
Erythrocytes orange
Connective tissue green 
Cytoplasm brown
Nuclei black/brown
Table 7: Shorrs method (Drury and Wallington, 1980)
Trichrome periodic acid Schiff (Tri-PAS)
Solutions:
1 1% aqueous periodic acid
2 Schiff's reagent
3 Sulphite rinse
15 ml of 10% potassium metabisulphite
15 ml of N/I HC1
105 ml of deionised water
4 Harris's Haematoxylin
5 Celestin Blue
6 1% acid alcohol (1% Cone HC1 in 95% methylated spirits)
7 2% Orange G in 5% aqueous phosphotungstic acid
(stand for 24 hours before use)
Method:
1 Slides to water
2 Rinse in deionised water
3 5 mins in 1% periodic acid
4 Rinse in deionised water
5 10 mins in Schiff's reagent
6 Without washing 3 x 3  min sulphite rinses
7 Wash in running water
8 3 mins in Celestin Blue
9 3 mins in Harris's Haematoxylin
10 Differentiate in 1% acid alcohol
11 Wash and blue in running water
12 Rinse in deionised water
Method (Contd.)
13 2 mins in Orange G
14 Wash in running water 2 mins
15 Dehydrate, clear and mount
Results:
Polysaccharide - Magenta 
Cytoplasm and RBC’s - Orange 
Nuclei - Blue Black
Table 8: Trichrome-PAS method (Bancroft and Stevens, 1982)
Solutions:
1 1.5% aqueous silver nitrate
2 0.5% hydroquinone (freshly prepared)
3 2.5% sodium thiosulphate (Hypo)
4 van Gieson stain
Methods:
1 Slides to water
2 Wash in several changes of deionised water
3 Place in silver nitrate solution in the DARK for 20 mins
4 Wash in 10 changes of deionised water
5 Reduce in hydroquinone for 5 mins
6 Rinse in deionised water
7 Treat with Hypo for 5 mins
8 Wash well in tap water
9 Counterstain with van Gieson for 4 mins
10 Without washing, dehydrate, clear and mount
Results:
Calcium deposits - Black
Table 9: von Kossa method (Drury and Wallington, 1980)
Alizarin red (Ph 7.0) modified
1 Xylene 1 min
2 Xylene 1 min
3 99 IMS 1 min
4 99 IMS 1 min
5 99 IMS 1 min
6 Running water 3 min
7 Distilled water 3 min
8 2% Alizarin red S pH 7.0 buffered using NaOH 10 min
9 Blot dry
10 99 IMS 3 dips
11 99 IMS 3 dips
12 Xylene 1 min
13 Xylene 1 min
(a) +ve controlled by 10% acetic acid for 30 mins to remove all forms c
++
Ca but oxalate crystals.
(b) -ve controlled by 0.3% HCL (0.1 N) for 30 mins to remove all forms
„  ++Ca .
Table 10: Alizarin red S method (Proia and Brinn, 1985)
Sudan IV (Scarlet R)
1 Dissolve 1.4 gms of Sudan IV in 200 ml of propylene glycol (propane 
1*2 diol), by heating to 100°C.
NB Do not allow the solution temperature to rise above 100°C.
2 When cool filter under vacuum.
Haemalum
1 Dissolve 0.5 gms of haematoxylin in 500 ml of deionised water.
2 Add 25 gms of potassium alum and dissolve, "(aluminium potassium
sulphate).
3 When dissolved add 0.1 gms of sodium iodate.
4 Add 0.5 gms of critric acid and 25 gms of chloral hydrate.
5 When dissolved pour into the stock bottle, date and expiry date.
Staining
1 Stain into Sudan IV (Scarlet R) for a minimum 5 mins.
2 Transfer to 85% propylene glycol (propane 1:2 diol) 2 mins (maximum
3 mins).
3 Transfer to 50% propylene glycol for 2 mins (maximum 3 mins).
4 Transfer to warm water 1 min.
5 Transfer to haemalum 4 mins (maximum 5 mins).
6 Transfer to deionised water and mount on to a microslide.
7 Coverslip with an aqueous mounting media.
8 When dry, seal with nail varnish.
9 Enter in the cutting and staining records (fats) book and date
and initial.
Results
Fat droplets, red/orange.
Table 11: Sudan IV method for fat (Knowles, personal communication)
Fig.2 Polaroid CU-5 Land camera (Necropsy and Histology)
Fig.3 Stereo dissection microscope and camera (Necropsy and Histology)
Microscopy (LM):
Fixed slices of kidneys were examined using a stereo-dissecting 
microscope. (Wild M3Z, Leitz Instruments Ltd), and photographed with a 
35 mm camera attached to the microscope (MPS-45, Leitz Instruments 
Ltd), (Fig.3).
Histological sections of kidney were examined with an Orthoplan micro­
scope (Leitz Instruments Ltd), and photographed using an attached 
35 mm Vario Orthomat camera (Leitz Instruments Ltd), (Fig.4). 
Statistics:
Data was recorded for each individual finding in each individual 
animal. Where possible these were combined to give group mean values 
for numerical data or group assessments for non-numerical findings. 
Haematology, clinical chemistry, organ weights and terminal body 
weights were analysed with the Mann Whitney U-test (level of 
signficance P<0.05) on combined male and female values.
Figure.4: Orthoplan microscope and Vario-Orthomat camera (Microscopy)
Chapter 3
Anatomy, histology and physiology of the baboon kidney
The kidneys are paired organs situated in the lower part of the 
abdomen, immediately dorsal to the peritoneum. The left kidney is
more caudal than the right (Fig.5) in contrast not only to other
species of nonhuman primate but also to man (Fig.6). The hilus is an 
opening into the concave medial border. Through it pass the renal 
blood vessels, nerves and pelvis. The two ureters pass caudally from 
the pelvis, over the psoas muscle, ventral to the common iliac vessels
and terminate on the dorsolateral surface of the urinary bladder. An
adrenal gland lies over the cranial pole of each kidney often in 
contact with the kidney and sometimes toward the medial side. This 
arrangement is important in adrenal ectopism in the kidney and which 
occurs in baboons (Skelton-Stroud, 1981).
Baboon kidneys, like those of the marmoset and other species of 
monkey, are smooth in outline and smooth surfaced (Figs.7 and 8).
They show no evidence of external lobulation in contrast to those of 
foetal and neonatal humans and the cow, bear and elephant (Figs.9 and 
10). The internal structure revealed in both transverse and longi­
tudinal sections shows a single fore-shortened papilla or papillary 
ridge (Fig.11). Baboons are therefore unipapillate like almost all 
other nonhuman primates and lower mammals and do not possess a true 
pelvis divided into proper calyces. Such structures among primates 
are found only in man and in the spider monkey (Ateles spp.) (Fig.12). 
In the spider monkey two or three papillae can be found, and in man 8 
to 18 papillae may be present. In the baboon the papilla is surrounded 
by the expanded pelvis (Fig.11).
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Fig.5: Anatomical position of kidneys in the baboon (Swindler and Wood, 1973)
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Fig.6: Anatomical position of the kidneys in man (Swindler and Wood, 1973)
Fig.7: Baboon kidneys are smooth in outline (xl)
Fig 8: Marmoset kidneys show no external lobulation (xl)
(Material provided by Dr Mary Tucker)
Fig.9: Lobulated kidneys from a cow
(Photograph provided by Prof. D. Kelly)
Fig.10: Human kidneys
(Photograph provided by Dr. J. McClure)
Figure 11: Short papillary ridge in the baboon, surrounded by the 
expanded renal pelvis (arrow). (TriPAS x20)
Figure 12: Spider monkey kidneys have more than one papilla 
(Material provided by Professor J.A. Roberts)
Blood Supply:
Generally, the intrarenal pattern of arteries in nonhuman 
primate kidneys is similar to that of man. The abdominal aorta gives 
rise to the renal arteries which pass into each kidney at the hilus. 
Each artery branches into a dorsal and ventral division which then 
subdivide into interlobular vessels. These branch into the arcuate 
arteries at the corticomedullary junction, and then form interlobular 
arteries which pass towards the capsule giving off afferent arterioles 
to supply the glomerular capillaries. Blood is drained from the 
glomeruli by efferent arterioles leading into peritubular capillaries 
interspersed between the bundles throughout the medulla.
Radio-labelled microspheres have been used in both prenatal and 
postnatal animals to measure systemic ]alood flow. Values ranged from 
1.86 after birth, to 2.96 at 33 days, to 1.99 ml/min/g. tissue at 61 
days (Paton and Fisher, 1984). Using xenon gas inhalation techniques, 
renal cortical blood flow values of 150 to 280 ml/lOOml/min. were 
obtained in six baboons (Wozney et al, 1984). Differences were noted 
by this method for parenchymal flow which had a lobular pattern with 
higher values when compared to the collecting system values of 0 to 
20 ml/100 ml/min (Gur et al, 1984).
Histology:
Glomeruli are present throughout the cortex from immediately 
beneath the capsule and surface to the corticomedullary junction 
(Fig.13) confirming the observation by Stinson (1971). This 
contrasts with the aglomerular cortex corticis in man and the rat, and 
is an interesting divergence in structure when considering the close 
phylogenetic relationship of both man and monkey among primates.
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Figure 13: Glomeruli are present immediately beneath the capsule in
baboon kidneys (HEx25)
The subcapsular glomeruli are often small and poorly developed 
in contrast to those deeper in the cortex and in particular to those 
near the corticomedullary junction (Figs.14 and 15). Granules may be 
seen in the juxtaglomerular cells by routine light microscopy and high­
lighted by histochemical staining methods eg, trichrome periodic-acid 
Schiff (TriPAS) (Fig.16).
Similar highlighting of the microvilli of the brush border in 
the proximal convoluted tubules (PCT) may be achieved by the same 
TriPAS staining method, as well as the tubular basement membrane 
(Fig.16).
The bulk of the cortex comprises proximal tubules since the PCT 
is the longest and most convoluted portion of the nephron. The structure 
of the baboon kidney is comparable at cellular level to that of man, 
with the exception of the single papilla ending in a short ridge. The 
papillary collecting ducts are lined by tall columnar epithelium and 
open into the pelvic space where the papilla tip is covered by epithelium 
usually one or two cells thick (Fig.17). However, pelvic urothelium 
can be reflected around to cover the entire papilla and invest the 
openings of some ducts giving a stratified appearance (Fig.18).
There is little data published on the quantitative aspects of 
the nonhuman primate kidney. Ratios of cortex to medulla show that in 
man the cortex is relatively thin, while in the baboon the cortex is 
thicker with a ratio of 1.8:1 (Dicker and Morris, 1972). More recent 
data obtained from immature yellow baboons gave a range of ratios 
ranging from 3.1:1 to 7.1:1 (Condron, personal communication).
Quantitative glomerular morphology has been studied in the 
baboon in relation to changes induced by diabetes (Stout et al, 1986),
Figure 14: Immature subcapsular glomeruli in the baboon (HEx80)
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Figure 15: Veil developed corticomedullary glomerulus in a baboon(HEx80)
Figure 16: Granules in the juxtaglomerular cells (TriPASxl27)
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Figure 17: Papilla tip epithelium is two cells thick (HExl27)
Figure 18: Urothelium may be reflected round the papilla (HEx20)
and showed age-related changes similar to those in man. Diabetes- 
related changes were also similar in the two species.
Physiology:
Baboons have proved useful for urological research. A wide 
range of tests including diuretic renograms, sistograms, intravenous 
pyelograms as well as more conventional urinalysis and serum bio­
chemistry yielded dafa which were comparable to man (Goosen, Dormehl, 
du Plessis and Walters, 1982). Renal plasma flow and creatinine 
clearance (glomerular filtration rate) values in the intact baboon were 
150 ml/min and 42 ml/min in kidneys weighing 100 gms in baboons of 14 kg 
live weight (Johnston, van Heerden, van Zyl, van Zyl, Retief et al, 1968). 
The unique papilla pattern of the spider monkey was thought to provide a 
better comparison of renal function to man bearing as a species, more 
structural similarity. However, the GFR of 2.7 ml/min/kg was comparable 
to man at 1.73 ml/min/kg. Renal plasma flows of 11.1 ml/min/kg in the 
spider monkey and 9.4 ml/min/kg in man were also comparable (Table 12.). 
The maximum concentrating ability were similar in spider monkey, man 
and the macaque species, (Goodman, Wolf and Roberts, 1977).
Baboon Spider Monkey Man
GFR 3.9 2.7 1.73
RPF
(units ai
10.7 
*e ml/min/kg
11.1 9.4
Table 12: Kidney physiological data in 3 primate species 
Clinical chemistry data pertinent to normal renal function in the 
baboon ape given in Table 13.
MALES FEMALES
95% RANGE N
140 - 160 116
3.4 - 5.7 116
3.63 -10.55 116
4.87 - 8.33 116
20 - 59 116
17 - 66 116
1009 - 3318 116
69.4 - 92.4 116
49.5 - 64.3 116
2.0 - 5.7 116
6.0 - 11.0 116
10.8 - 17.6 116
13.0 - 23.2 116
2.23 - 4.74 75
0.26 - 0.94 75
2.31 - 3.01 45
0.71 - 0.96 45
0.28 - 2.55 45
66 - 111 84
39.5 - 53.0 116
1.6 - 4.7 116
4.7 - 9.2 116
8.1 - 15.1 115
10.1 - 19.5 112
ASSAY 95% RANGE N
Na 143 _ 160 116
K 3.5 - 5.5 116
GLUC 4.04 - 8.51 116
UREA 4.82 - 9.67 116
ASAT 20 - 47 116
ALAT 19 - 72 116
AP 1365 - 3368 116
PROT 71.6 - 89.4 116
% ALB 49.4 - 67.0 116
% Al 2.2 - 6.0 116
% A2 5.3 - 10.1 116
% B 10.5 - 17.8 116
% G 12.7 - 24.1 116
CHOL 2.50 - 4.86 75
TG 0.32 - 1.08 75
Ca 2.33 - 2.88 45
Mg 0.68 - 0.90 45
P04 0.95 - 2.47 45
CREAT 68 - 112 84
ABS.ALB 40.4 - 54.5 116
ABS. Al 1.7 - 4.7 116
ABS. A2 4.2 - 8.5 116
ABS. B 8.2 - 16.0 116
ABS. G 10.0 19.2 112
Na = sodium, K = potassium, Glue = glucose, ASAT = aspartate amino trans­
ferase, ALAT = alanine amino transferase, AP = aklaline phosphatase,
PROT = total protein, % ALB = percentage albumin, Ofi, «2> P and Y 
globulin respectively, CHOL = cholesterol, TG = triglycerides, Ca = 
calcium, Mg = magnesium, PO4 = phosphate, CREAT = creatinine, ABS.
ALB = absolute albumin, a*, «2) P and y globulin respectively.
Table 13: Normal clinical chemistry parameters in immature yellow baboons
Chapter 4
Naturally occurring kidney disease in the baboon (Papio spp.)
A survey of naturally occurring pathological lesions seen at both 
necropsy and subsequent microscopy, was made upon kidneys from control 
baboons in toxicological studies performed during the period from 1971 
to 1986.
Results
A total of 263 pairs of kidneys were weighed (132 males, 131 females). 
The absolute and relative values are given in Table 14. At necropsy 
and microscopy 217 pairs of kidneys were examined (108 males, 109 
females). The ten most commonly observed microscopic lesions are given 
in Table 15.
Inflammatory lesions were the most common and those involving 
lymphocytes predominated (62%). Occasional plasma cells, polymorpho­
nuclear leukocytes or eosinophil leukocytes were sometimes seen mixed 
in the infiltrate. Those infiltrates in the cortical interstitium or 
adjacent to blood vessels were small and loosely aggregated (Fig.19). 
Those adjacent to,or surrounding solitary glomeruli were slightly 
denser packed (Fig.20). Even when numerous and multifocal the infil­
trates did not occupy significant areas of the cortex in total. 
Identifiably altered tubules which showed epithelial regeneration in 
addition to the cellular infiltrates were classified as tubulo- 
interstitial nephritis (Fig.21). Although a few such infiltrates were 
sufficiently obvious as to be seen at necropsy as minute pale areas on 
the kidney surfaces, the majority were microscopic, deeper in the 
cortex and only slight in severity. Among the 9% affected (12 males, 7 
females), 6% (8 males, 4 females) had nonspecific foci of lymphocytes in
SEX N WEIGHT MIN MAX MEAN SD SE TYPE
MALE 132
BODY
BRAIN
KIDNEYS
4000
123.5
18.8
11800
209.9
48.3
6974
150.2
30.6
1664
13.7
6.4
145
1.2
0.6 ABSOLUTE
VALUES
FEMALE 131
BODY
BRAIN
KIDNEYS
3000
100.4
16.6
10900
175.8
43.4
6243
137
27.5
1450
11
5.2
127
1.0
0.5
MALE
FEMALE
132
131
KIDNEYS
KIDNEYS
0.30
0.26
0.60
0.67
0.44
0.45
0.05
0.06
0.004
0.005
PERCENTAGE
BODY
MALE
FEMALE
132
131
KIDNEYS
KIDNEYS
13.75
12.78
29.63
31.33
20.18
20.05
3.65
3.95
0.32
0.35
PERCENTAGE
BRAIN
Table 14: Kidney weights as absolute/relative values from 263 baboons
LESION AREA MALE % FEMALE % TOTAL %
1 Lymphocytic foci C 68 63 69 63 137 63
2 Multinucleate cells M 57 53 57 53 114 53
3 Altered glomeruli C 57 52 43 39 100 46
4 Mineralisation M 32 30 26 24 58 27
5 Epithelial inclusions Pe 30 28 32 29 62 28
6 Vacuoles Pe .Pa 18 17 25 23 43 20
7 Ectopic nephrons Pp 16 15 19 17 35 16
8 Pyelitis Pe 15 14 18 16 33 15
9 Tubular basophilia C 14 13 10 9 24 11
10 Tubulointerstitial nephritis C 12 11 7 6 19
1
9
(C = cortex, M = medulla, Pe = pelvis, Pa = papilla, Pp = peripelvic area)
Table 15: Incidence of ten most common microscopic lesions
in 217 pairs of baboon kidneys (108 males, 109 females)
Figure 19: Interstitial lymphocytic infiltrate (HEx80)
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Figure 21: Tubulointerstitial nephritis (HEx50)
Figure 22: Chronic interstitial nephritis (HEx20)
addition to the focal tubulointerstitial change. Four examples of 
chronic interstitial nephritis were found (1.8%), characterised by 
radial areas of shrunken irregular tubules and significant interstitial 
fibrosis, and sparse inflammatory cells (Fig.22). Focal tubular baso­
philia with thickened basement membranes occurred in very small foci 
in 13 males and 10 females (10.5%). Almost all foci were solitary, 
without affected glomeruli and only few showed occasional lymphocytes 
present (Fig.23). Lymphocytes were the main components of two further 
inflammatory conditions; pyelitis and papillitis. They sometimes 
occurred together. Pyelitis (15%) showed infiltrates beneath and 
within the pelvic urothelium, was usually slight, nonprogressive and 
situated high in the angle of the pelvis (Fig.24). Papillitis was 
sometimes a continuation of pyelitis into medullary tissue, but 
generally occurred as a separate entity. In one individual male 
animal, a trace to minimal bilateral papillitis showed as tubulointer­
stitial inflammation in the papilla. It was accompanied by epithelial 
hyperplasia at the papilla tip with a few mitotic figures. A few 
collecting ducts showed several vesicular nuclei the importance of 
which was unclear. Follicular lymphocytic infiltrates were uncommon.
A total incidence of 5% comprised 6 cases in the cortex and a further 
4 cases in peripelvic tissues. Single small polymorphonuclear leuko­
cyte foci (11%) were generally seen adjacent to large blood vessels in 
the lateral cortex and only seldom in the cortical interstitium.
Similar small foci of polymorph aggregations within the tubule lumen 
were seen in 5 animals and classified as focal trace pyelonephritis.
Many animals showed altered glomeruli. Such glomeruli were 
single, random and showed no preferential location within the cortex.
Figure 23: Tubular basophilia (HEx50)
Figure 24: Pyelitis (HEx40)
Changes included slight periglomerular fibrosis, varying degrees of 
thickening of Bowmans capsule and sclerosis of the tuft, leading to 
relatively acellular hyaline tufts, strongly positive with stains for 
mucopolysaccharides (Fig.25). Two baboons showed linear areas 
containing several sclerosed glomeruli immediately below the capsule.
A few animals showed solitary glomeruli with focal glomerulonephritis 
characterised by proliferative changes and mitotic figures in the tuft.
The total incidence of focal glomerular change was 46%.
Noninflammatory changes in the medulla included multinucleated 
epithelial cells, vacuolated epithelial cells, mineralisation and 
mitotic figures. Multinucleated cells were present in the epithelium 
of the collecting tubules, usually towards the papilla tip in 53% (57 
males, 57 females) (Fig.26). Affected cells showed varying numbers of 
nuclei ranging from three to ten or more. Such large morula-like intra- 
cytoplasmic groups caused the cells to bulge into the lumen of the tubule. 
No viral inclusions or other causative factors were identified.
Similar multinucleated cells were found in other areas of the renal 
urothelium but at much lower incidences; papilla tip epithelium (2%); 
pelvic epithelium (3%) and ureter epithelium (17%). Binucleate cells 
were common in those urethelial cells bordering the lumen. Vacuolated 
epithelial cells also occurred in papilla epithelium (11%), either at 
the tip or laterally, and also in pelvic epithelium (9%). Interstitial 
mineralisation in the medulla was frequently multifocal and common 
(27%). No inflammatory reaction or signs of degeneration were noted 
(Fig.27). Some foci were sited immediately below the papilla tip 
epithelium. All foci were positive to stains for calcium salts.
Mitotic figures were rare and were seen in only 5 baboons. In one
Figure 25: Glomerular sclerosis and hyaline change (HExlOO)
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Figure 26: Multinucleate cells in papilla collecting tubules (Shorrs x64)
male animal with tubulointerstitial papillitis, three figures were 
found in a collecting tubule and one at the papilla tip, in addition 
to other changes which included hyperplasia and some vesicular nuclei. 
Four other animals (1 male, 3 females) each showed one or two mitotic 
figures also in collecting tubule epithelium, but unaccompanied by 
other changes. Mitoses therefore occurred in 2%.
No evidence of RPN was found. One kidney in a male baboon 
showed an irregular distortion of the papillary area at microscopy 
but no other microscopic changes were noted (Fig.28).
In addition to vacuoles in the pelvic epithelial cells, intra- 
cytoplasmic inclusions were also found. They were brightly eosinophilic 
and retractile bodies. They were round, ovoid or curved linear in 
shape and could be found throughout the depth of the urothelium but 
were more commonly concentrated in the uppermost layers. Those 
inclusions in cells nearer the pelvic lumen were generally the larger 
than those deeper in the urothelium (Fig.29). An incidence of 28% 
was noted in pelvic urothelium. None were seen in papilla tip 
epithelium, but they were sometimes found in ureter epithelium when 
the ureter was present in the section.
Developmental analomalies included a single example of a cortical 
cyst, ectopic nephrons (16%) identified as isolated glomeruli or small 
basophilic tubules in the peripelvic tissue (Fig.30), and the three 
linear subcapsular areas of sclerosed immature glomeruli. Two animals 
each showed single minute intratubular crystals, one in the cortex 
and one in the medulla. Both crystals had the physical shape and 
staining characteristics specific to calcium oxalate monohydrate.
Figure 27: Interstitial mineralisation in the medulla (HEx40)
Figure 28: Irregular papilla tip area, unilateral (HEx5)
Figure 29: Intracytoplasmic inclusions in pelvic urothelium (HExl60)
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Figure 30: Ectopic nephron in peripelvic tissue (HEx50)
Discussion
There is still little comprehensive published data on renal 
pathology in the baboon in spite of the accepted biomedical value of 
this particular species of nonhuman primate. Some of the lesions 
reported here show certain similarities to renal disease in man.
Among the different inflammatory lesions those including lympho­
cytes were the most common. Such infiltrates have been seen in other 
species of nonhuman primates including chimpanzees, marmosets, owl 
monkeys, galagos and pigtailed macaques. In baboons examined in field 
surveys and others in laboratory surveys, lymphocytic infiltrates were 
described as small and common (Weber and Greeff, 1973), with incidences 
varying from 8.6% (Kim, Eugster and Kalter, 1968), 24% (McConnell et 
al, 1974; Glaister, 1986), 36% (Skelton-Stroud, 1981) and 89% (Brack, 
1981). There has also been some variation in the terminology describ­
ing the range of lesions which include lymphocytic infiltrates. 
Infiltrates without accompanying glomerular, tubular or interstitial 
changes were described as mild subacute interstitial nephritis in 
chacma baboons examined in the field (McConnell et al, 1974). True 
interstitial nephritis or early pyelonephritis was used when infil­
trates were mixed and some tubular damage but no fibrosis was seen 
(Brack, 1981). When infiltrates were seen in the kidneys but also in 
the heart and liver, the kidney foci were described as nonsuppurative 
nephritis (Kim et al, 1968). The more comprehensive term of leukocyte 
foci to include both lymphocytic and mixed infiltrates has also been 
used (Glaister, 1986). It is important to differentiate between the 
apparently bland lymphocytic infiltrates and those with other histo­
logical changes of altered tubules, interstitial oedema or fibrosis.
Simple infiltrates may be considered as part of a general cellular 
response to viruses rather than specific renal disease since 
infiltrates are common in other organs of the same animals. Other 
causative agents such as bacteria (Leptospira spp.) and protozoan 
parasites (Toxoplasma spp.) have been suggested, but not substantiated 
in baboons (McConnell et al, 1974). Baboons are hosts to a variety of 
viruses (Kalter, 1965). The term tubulointerstitial nephritis is 
considered appropriate for the combination of cellular infiltrates and 
histologically altered tubules. An incidence of 21% was found in 
similarly immature baboons (Glaister, 1986). In this survey the 
incidence of this particular lesion at 9% and of chronic interstitial 
nephritis or fibrosis at 1.8% is important, especially with regard to 
predictive toxicology. Interstitial nephritis can sometimes be part of 
the renal response to some chemicals either as a result of direct toxic 
disturbance or as part of an immunological response (Heptinstall, 1983; 
Glaister, 1986). It is also very important to stress that the foci 
seen in individual baboons in this study of background renal disease 
were almost all microscopic and did not, in total, occupy a significant 
amount of renal tissue. Similarly, lymphocytic involvement in pyelitis 
and the less common papillitis were essentially very minor in terms of 
significant renal change. The lack of naturally occurring renal 
papillary necrosis (RPN) in these animals is important in relation to 
toxicological studies in particular but also to other types of study on 
renal function. Thus the failure to find papillary necrosis as a 
background lesion provides a perspective for interpretation of studies 
where papilla changes are induced by treatment. There are only rare 
published references to RPN in nonhuman primates. One single case,
species unspecified, was found in a survey on the natural incidence of 
pyelonephritis from 590 animals of which 7.8% showed renal lesions 
(Roberts, Clayton and Seibold, 1972). Two cases, described as focal 
papillary necrosis, were reported from 567 marmosets (Tucker, 1984).
The single unilateral example of an irregular and distorted papilla in 
this study remains of uncertain aetiology. Also related to this area 
of the kidney was the low incidence of mitotic figures. Baboon 
urothelium, like that of most mammals, usually has a very low degree 
of mitotic activity in vivo (Sharieff, Reich and Bonar, 1980). It 
does however possess the capacity for a significant rapid increase.
This is again important when considering the histopathology of 
reparative and regenerative processes following renal insult, and 
papilla damage in particular, to drug-induced changes.
The multinucleated epithelial cells of the collecting tubules 
have been seen in macaque monkeys (Seaman, 1986) and previously report­
ed in baboons (Skelton-Stroud and Glaister, 1987), but have not been 
reported in man. It would be imprudent to represent such cells as 
indicating preneoplastic change since even after considering 
variations in background influences there have been no references in 
the literature to increased incidences of renal neoplasia in such 
animals. Multinucleated cells do occur in the kidneys in man in 
multiple myeloma (Suki and Eknoyan, 1976). Such such cells are present 
within the interstitium and are probably derived from macrophages 
(McClure, personal communication).
Mineralisation in the medulla interstitium in the papilla is 
common in nonhuman primates (McConnell et al, 1974; Glaister, 1986; 
Skelton-Stroud and Glaister, 1987). Similar calcium deposits have been
found in routine examinations of human kidney material, particularly 
from children (Heptinstall, 1983). The precise mechanisms are not 
fully understood but ionic imbalance is involved. Studies of the meta­
bolism of calcium in monkeys show certain similarities to man (Harris, 
Moor and Wanner, 1966).
The animals examined in this survey were almost all adolescent 
animals. Glomeruli of varying sizes, due to their immaturity, were 
present throughout the cortex, from immediately below the capsule to 
the corticomedullary junction. In man an aglomerular zone exists 
immediately below the capsule, the cortex corticis. In baboons the 
subcapsular glomeruli were often smaller and showed an apparent hyper- 
cellularity. Whilst those of the inner cortex and corticomedullary 
junction were significantly larger. Glomerular pathology was sparse 
and relatively insignificant. This was in spite of the high numbers of 
individual animals that showed altered glomeruli. Those showing 
associated periglomerular lymphocyte foci were considered to be part of 
the more general response to viruses and not to represent true 
glomerular disease. The remaining changes of periglomerular fibrosis, 
sclerosis and hyaline change occurred only in a few solitary scattered 
glomeruli. They were hardly accounted as significant changes overall.
A similar range of glomerular change was noted in a group of baboons of 
different ages, ranging from 1 year to 10 years old (Brack, 1981). But 
in contrast, no glomerular pathology was described in wild-caught 
baboons of varying ages examined in the field (McConnell et al, 1974). 
Such variations may be due to different histological base-lines during 
examination. Glomerular sclerosis and hyalinisation are common in 
infant humans (Emery and MacDonald, I960) and histologically resemble
the obsolescent changes of old age. It has been suggested that these 
altered glomeruli may represent a sorting out of early or late incom­
pletely formed nephrons. In baboons, as in man, the affected glomeruli 
are sparse in relation to the total glomerular population. Baboons may 
also be host to a variety of parasitic infections. These range from 
schistosomiasis and malaria to a variety of helminths. No glomerular 
lesions have been associated with such infections (Brack et al, 1972; 
Skelton-Stroud and Glaister, 1987). Baboons do however, react similarly 
to man with a proliferative glomerulonephritis following the insults of 
bacterial septicaemia or certain chemicals (Heidel, Giddens and Boyce, 
1981; Leary, Sheffield and Strandberg, 1981; Skelton-Stroud, unpublished 
observations). This suggests that baboons may be more appropriate as 
animal models for the study of human glomerular disease than those 
other species of nonhuman primate with naturally occurring glomerulo­
nephritis (Giddens, Boyce, Blackley and Morton, 1981).
The presence of single crystals in kidney tissue of animals in 
this study, albeit at a very low incidence, is of importance since 
crystals may also be part of the renal response to experimental treat­
ment. Naturally occurring oxalate nephrosis has been reported in non­
human primate kidneys and ascribed in baboons to dietary habits which 
may include wild grapes known to contain high levels of oxalic acid 
(McConnell et al, 1974). Oxalate nephrosis has also resulted from the 
administration of a number of antibiotics including ampicillin, 
penecillin-streptomycin, sulphadimethoxine and gentamycin, to monkeys 
with diarrhoea (Giddens et al, 1981). Other examples of oxalate 
crystal deposition have followed experimental administration with 
either polyethylene glycol (Prentice and Majeed, 1978) or ethylene
glycol used as antifreeze (Roberts and Seibold, 1969). Other examples 
seen in monkeys of different species and from different batches 
identified no definite cause (Weber, Brede, Retief, Retief and Melby, 
1971; Skelton-Stroud and Glaister, 1987). It is not possible to 
precisely identify the different influences of dietary variation, 
stress, accidental exposure to chemicals and other conditions to which 
monkeys caught in their natural habitat have been exposed. It is 
reasonable however to accept that improvements in all aspects of 
mananagement from capture to utilisation in biomedical research have 
produced a degree of uniformity in health status that allows monkeys 
to be reliable laboratory animal models for human disease.
In both rats and dogs there is also a range of naturally occur­
ring renal pathology. It is important to contrast and compare such 
lesions against those encountered in baboons to provide a perspective 
for selection of the appropriate species for investigation. Overall 
the range of changes is suprisingly similar in the three species with 
few significant differences. In male rats hyaline droplets occur in 
proximal tubular epithelial cells and are related to reabsorbtion of 
«2u globulins. They may increase or decrease as a response to 
treatment. Similarly basophilic tubular epithelium is again common in 
male rats, and may confound interpretation of regenerative responses 
to treatment-related damage. Mineralisation in contrast to the baboon 
and dog, is seen predominantly in female rats at the corticomedullary 
junction and may vary with treatment. Dogs can frequently show minor 
foci of pyelitis or interstitial nephritis characterised by lympho­
cytic infiltrates. Papilla mineralisation is also relatively common 
in both male and female dogs. The more common lesions in rats and 
dogs are summarised in Table 16.
Rat Dog
Male Female Male Female
Leukocyte foci 12 7 Leukocyte foci 4 1
Hyaline droplets 15 0 Interstitial nephritis 6 6
Tubular regeneration 32 4 Pyelitis 4 7
Mineralisation 0 6 Mineralisation 74 69
Hydronephrosis 10 10 Granuloma 4 4
Overall % 69 27 Overall % 88 87
Table 16: Comparative incidences of renal lesions in rat and dog 
(Glaister, 1986)
This survey of adolescent, wild-caught and laboratory-maintained 
baboons has reported the types, incidence and severity of naturally- 
occurring renal disease. It is important to understand that variations 
in incidence between individual animals can occur, as well as between 
animals of different batches or origins, and that the data reported 
here should be considered as guidelines for the lesions encountered. 
Overall the pathology described was very minor, although varied, and 
unlikely to either prejudice or complicate renal studies intended to 
provide data for comparison with man.
Chapter 5
Experimental administration of nonsteroidal anti-inflammatory 
compounds (NSAIDs) to nonhuman primates (baboons)
The objective of the study was to assess and compare toxico- 
logical effects, especially any nephrotoxic responses, between two 
NSAIDs. Both compounds were members of the oxicam group, an experi­
mental compound CGP 13 214D and Piroxicam (Feldene®, Pfizer) a 
marketed compound with the chemical formula 4-hydroxy-2-methyl-N-(2- 
pyridyl)-2H-1,2-benzothiazine-3-carboxamide-l,1-dioxide.
Materials and Methods
The compounds were administered by oral gavage, daily for three 
months. The oral route was chosen since that was the most common 
route of administration for such anti-inflammatory compounds in man. 
The study design comprised five groups, each of six animals (3 male, 3 
female) treated for at least 91 days. Test compounds were prepared 
freshly each day and suspended in a solution of 1% methocel vehicle 
(Methyl cellulose 400, Ciba-Geigy), and administered orally by gavage 
at a rate of 5ml per kg body weight. The following doses were used 
for each respective dose group:
Control
20 mg/kg Piroxicam*
6 mg/kg Piroxicam*
6 mg/kg CGP 13 214D 
2 mg/kg CGP 13 214D
Group 1 Vehicle only 
Group 2 = 0.4% w/v 
Group 3 = 0.12% w/v 
Group 4 = 0.12% w/v 
Group 5 = 0.04% w/v
Results
Necropsy: At 20 mg/kg Piroxicam one male animal was necropsied before 
schedule. Diffuse congestion of the large intestine was found, and 
minute lesions on the papilla of each kidney. In the remaining 
animals fluid faeces and large intestine congestion was seen in one 
male and one female respectively. A single 5 mm pale areas was noted 
on the right kidney of one female animal, and a 3 mm depressed area on 
the right kidney of another female baboon.
At 6 mg/kg Piroxicam no significant comments were made upon the 
gastrointestinal tract. Kidney lesions comprised a minute dark area 
on the papilla of the left kidney in one female animal; a 4 mm pale 
area on the right kidney and a minute dark focus on the papilla of the 
left kidney in another female.
At 6 mg/kg or 2 mg/kg CGP 13 214D no gastrointestinal findings 
were noted. Minute dark foci were seen on the papilla of the left 
kidney, each in two female animals at 6 mg/kg, and mottled kidneys in 
a single female baboon at 2 mg/kg CGP 13 214D.
No similar lesions were found in untreated control animals. 
Microscopy:
Lesions attributable to the administration of Piroxicam and CGP 
13 214D were found variously in the gastrointestinal tract and the 
kidneys.
At 20 mg/kg Piroxicam varying degrees of gastrointestinal 
irritation were present in different individuals at this dose level. 
Similar but lesser changes occurred at 6 mg/kg Piroxicam. At 6 mg/kg 
and 2 mg/kg CGP 13 214D minor inflammatory changes were also present
A range of lesions was seen in the kidneys. At 20 mg/kg Piroxi­
cam unilateral papillary necrosis was found in one male animal (Fig.31). 
Pale yellow crystals were also present, more clearly visible under 
polarised light (Fig.32). Epithelial hyperplasia at the papilla tip 
varied from minimal to marked and was characterised by small basophilic 
cells in papillary projections (Fig.33). Some of the cells were vacuo­
lated. In the inteFstitium at the edge of the lesion basophilic sheets 
of mineralisation were seen with crystals embedded (Figs.34, 35).
Similar basophilic material enhanced the tubules near the papilla tip. 
Basophilic debris indicating interstitial necrosis was present immed­
iately at the edge of the mineralised deposit at its highest concen­
tration, but was also present in small foci higher in the papilla. The 
papillary collecting ducts also showed epithelial hyperplasia with occa­
sional mitotic figures. Some of the hyperplastic epithelial cells 
present in the pelvis showed foamy or vacuolated cytoplasm. Their 
presence in the pelvic space was probably artefactual fragmentation. 
Generally the RPN was well defined and discrete. RPN was accompanied 
by a moderate tubulointerstitial inflammation in the cortex. Retro­
spective examination of additional slices of kidney tissue using a 
stereo dissection microscope showed a large irregular cavity on the 
papilla tip of one kidney (Fig.36). In the other kidney interstitial 
necrosis showed significant areas in the centre of the papilla lacking 
identifiable structure and with some oedema (Fig.37). In the lateral 
areas of the papilla tubular structures were enhanced by basophilic 
material. Moderate papilla tip and collecting duct epithelial hyper­
plasia was present with a few mitotic figures in the latter. A few 
minute crystals were present in the the central interstitium
..v.^j
Figure 31: Unilateral RPN with 20 mg/kg Piroxicam (HEx5)
i
Figure 32: RPN shows prolific epithelial hyperplasia (arrows)
mineralisation (M) and crystals (C) (Polarised light, HEx20)
Figure 33: Hyperplastic epithelial cells are small and basophilic. 
Some are vacuolated (arrows) (HEx50)
Figure 34: Interstitial mineralisation (M) is present together with 
interstitial necrosis (N) and yellow crystals (C) (HEx50)
Figure 35: Crystals present in the mineralised areas and also free 
in the pelvic space (Polarised, HEx50)
Figure 36: Papilla tip irregularity seen through a stereo dissection
Figure 37: Epithelial hyperplasia(H), papilla oedema(O) and necrosis(N).
in the other kidney of the animal with RPN (HEx20)
immediately below the epithelium (Fig.38). The crystals stained 
positive for calcium and oxalate constituents (Fig.39). SEM and 
X-ray diffraction data also supported this structure (Figs.40,41). 
Epithelial cells present in the pelvic space showed some vacuolation.
In both kidneys the pelvic epithelium was unaffected. The areas of 
RPN were well defined and discrete and unaccompanied by changes in 
the cortex.
Within the same dose group (20 mg/kg Piroxicam) a female animal 
showed moderate papillary interstitial hyperaemia and haemorrhage 
together with minimal focal epithelial hyperplasia (Fig.42). This was 
also seen using the stereo dissection microscope (Fig.43). Occasional 
mitotic figures were present in the papillary collecting ducts. With 
the exception of small amounts of basophilic material in the interstitium 
of one kidney, there were no other changes. A similar but lesser 
degree of papilla haemorrhage and epithelial hyperplasia was seen 
unilaterally in one other female animal. The remaining kidneys in this 
group of animals were similar to controls and background data.
At 6 mg/kg Piroxicam (Group 3), RPN was again found unilaterally 
in one female animal. Moderate epithelial hyperplasia was 
present with mitoses in papillary collecting ducts and minimal inter­
stitial necrosis (Fig.44). A few collecting ducts showed several 
vesicular nuclei the significance of which was uncertain. Epithelial 
hyperplasia, interstitial haemorrhage with oedema and crystal deposition 
were seen unilaterally in anothef female (Fig.45). The remaining 
female in this dose group showed only moderate epithelial hyperplasia 
with mitotic figures in collecting duct epithelium. Male animals were 
generally comparable to controls and a single mitotic figure was seen 
at the papilla tip in one kidney of one individual.
Figure 38: Crystals beneath the epithelium in the papilla interstitium
(Polarised>HEx80) of the same animal in Figure 37
Figure 39: Crystals stain positive for calcium oxalate with
Figure 40: SEM shows structure of crystals within the interstitium (xl,600)
CRYSTALLINE DEPOSIT IN RENAL PAPILLA 
-.25 <-> 20.36 KEV.
Figure 41: X-ray diffraction analysis of interstitial crystals shows only 
calcium present (copper is from processing) suggesting oxalate rather than
phosphate
Figure 42: Papilla interstitial hyperaemia with haemorrhage 
at 20 mg/kg Piroxicam (HEx50)
Figure 43: Dark areas in the papilla interstitium (arrows) in a female 
at 20 mg/kg Piroxicam, seen in Bouin's fixed tissue with a
stereo dissection microscope (x40)
Figure 44: Unilateral RPN in a female animal at 6 mg/kg Piroxicam (HEx5)
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Figure 45: Moderate epithelial hyperplasia at the papilla tip and 
base of the collecting ducts on the margins of the RPN
(HEx50)
At 6 mg/kg CGP 13 214D (Group 4) variation in the severity between 
kidneys in the same animal was again found. Interstitial haemorrhage 
and oedema with subepithelial crystals occurred in one kidney of a male 
baboon together with a trace of interstitial basophilic material and a 
low grade tubular dilation (Fig.46). Only haemorrhage and epithelial 
hyperplasia with some basophilic interstitial material were seen in the 
other kidney. A few small intratubular crystals were noted in another 
male. In a female baboons a moderate multifocal tubulointerstitial 
nephritis was seen accompanied by minimal papilla tip epithelial hyper­
plasia, including a single mitotic figure, and some interstitial 
mineralisation immediately below the epithelium. The other kidney 
showed similar but lower grade changes in the papilla. Only one other 
female showed a unilateral low grade epithelial hyperplasia comparable 
to that seen in a control baboon.
At 2 mg/kg CGP 13 214D (Group 5) male baboon kidneys were generally 
comparable to controls with one exception. A single kidney displayed 
epithelial hyperplasia above that seen in a control animal and in 
addition showed some evidence of interstitial change with a low level 
of interstitial necrosis and papillitis with inflammatory cells also in 
the papillary vessels (Fig.47). Kidneys in females were, with one 
exception, similarly comparable to control and base-line data. A 
moderate focal papilla epithelial hyperplasia with crystals and 
inflammatory cells was seen together with a focus of sub acute inter­
stitial nephritis containing a crystal in the cortex of one kidney 
(Fig.48).
In control animals (Group 1) one kidney in a female baboon showed 
a very low grade focal hyperplasia of papilla tip epithelium (Fig.49).
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Figure 46: Unilateral interstitial oedema with crystals in a male 
animal at 6 mg/kg CGP 13 214D (HEx50)
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Figure 47: Epithelial hyperplasia, interstitial necrosis and papillitis 
in a female animal at 2 mg/kg CGP 13 214D (HEx50)
• %  \  » « v /  v ; ^  • •  *
o* * xft '• ^ X'-- * <•> '97* \  - • ■ »•■■
* *  '• " *' ,/* .V
w*
4» e v '5 •*% ^
-*« •*«<->*.* '* / •
#Vv> • m* (K V  * / , '• » ’/* • • » v ( * *s, ^ . 04 *>1 # %»
Figure 48: Subacute inflammatory infiltrates in a female animal at
2 mg/kg CGP 13 214D (HEx50)
Figure 49: Unilateral low grade epithelial hyperplasia in a control 
baboon (HEx64)
This together with background data described in chapter 4 was used as 
a base-line for comparison with treated animals at all dose levels. A 
small dilated medullary tubule in one kidney of a male baboon 
contained a single crystal.
Sections stained for lipids, from animals representative of all 
groups, showed no worthwhile histological changes.
There were no strikingly significant alterations in the results 
of clinical chemistry assays in treated animals when compared to 
controls. Slight increases in urea levels were noted at a low 
incidence in the majority treated with 20 mg/kg Piroxicam. Levels 
were not consistently raised, occurring mainly in the middle of the 
study. Similarly slight urea increases occurred in a single animal at 
6 mg/kg Piroxicam and two animals at 6 mg/kg CGP 13 214D. Slight 
decreases in alkaline phosphates (AP), total protein and absolute 
albumin were seen in all treated groups. AP changes showed no 
specific trend or emphasis. Alterations in protein were mainly in 
albumin and showed some slight emphasis at 20 mg/kg Piroxicam, the two 
respective 6 mg/kg groups were comparable and the 2 mg/kg CGP 13 214D 
least affected. Similar changes have been seen in other studies with 
NSAIDs. Overall the clinical chemical changes were very minor and 
generally non specific in regard to renal injury except for urea 
changes.
Haematological data displayed a tendency toward increased 
leukocyte counts in treated animals, particularly those with gastro­
intestinal lesions. The incidence was higher in those which received 
Piroxicam.
Urinalysis showed intact erythrocytes and/or haemoglobin in the 
urine of both control and treated animals at various times during the 
study. A moderate haemoglobinuria occurred in two females at 20 mg/kg 
Piroxicam early in the study and it persisted in one animal. These 
animals showed microscopic papilla interstitial haemorrhage. No 
crystalluria was noted in any baboon which showed histological 
evidence of crystals.
Discussion
Most of the published literature on NSAID investigations in non­
human primates refer to metabolic studies. The anti-inflammatory 
compounds investigated include diclofenac sodium (Stierlin, Faigle, 
Sallmann, Kung, Richter et al, 1979), nabumetone (Haddock, Jeffery, 
Lloyd and Thawley, 1984), the methane sulphonanilides PMS and DF-PMS 
(Krause, Kuhne and Schillinger, 1983), a substituted cinnamate ester 
RO 03-6037 (Marten, Ruane, East and Malcolm, 1983), a new salicylate- 
type fendosal (Warrander, Metcalf and Fromson, 1981), suprofen (Mori, 
Kuroda, Sakai, Yokoya, Toyoshi and Baba, 1985), piroxicam (Hobbs and 
Twomey, 1981), pirprofen (Egger, Bartlett, Yuan and Karliner, 1982), 
and isoxicam (Borondy and Michniewicz, 1984).
Non-narcotic analgesics and anti-inflammatory compounds have a 
variety of chemical structures and individual compounds can usually be 
placed into one of the following categories: salicylates, pyrazolones, 
pyrazolidines, indoleacetates, phenylacetates, proprionic acid 
derivatives, oxicams, proquazon or anthranilic acid derivatives. 
Piroxicam (Feldene®, Pfizer) is 4-hydroxy-2-methyl-N-(2-pyridyl)-2H- 
1,2-benzothiazine-3-carboxamide-l,1 dioxide, a member of the oxicam 
group and closely related to sudoxicam and isoxicam (Fig.50).
Metabolic studies with piroxicam in different species of laboratory 
animals have shown at 20 mg/kg, a plasma half-life of 2-9 hours in the 
rhesus monkey (Hobbs and Twomey, 1981) when compared to a much longer 
45 hours in man (Hobbs and Twomey, 1979). A significant proportion of 
the dose, some 22%, was recorded as unchanged drug in the monkey faeces 
after oral administration. It was reduced to 6% following parentral
Piroxicam
Sudoxicam
Isoxicam
Figure 50: Chemical structures of piroxicam, sudoxicam, isoxicam
(Hobbs and Twomey, 1981)
administration. It was concluded that 16% of the oral dose was 
unabsorbed, but 84% was bioavailable (Hobbs and Twomey, 1981). 
Qualitatively piroxicam is metabolised similarly by the rat, dog, 
monkey and man (Fig.51). Quantitatively however, pyridyl ring hydroxy- 
lation in man accounts for about 50% of a dose. An important point is 
that minor differences in structure can significantly influence 
metabolic pathways. Such structural variations are present in both 
sudoxicam and isoxicam and the major metabolic routes were different 
and only a small general pathway was shared by all three forms when 
investigated in the rat, dog and rhesus monkey (Wiseman, Chang and 
Lombardino, 1976). The differences were shown in similar metabolic 
studies with isoxicam [4-hydroxy-2 methyl-N-(5-methyl-3-isoxazolyl)- 
2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide] (C1849), plasma half- 
life in man was 22-45 hours and somewhat shorter, 20-35 hours in 
rhesus monkeys. It was extensively metabolised in all species and 
again hydroxylation accounted for 30-50% of the dose in man and 16% 
in the monkey. Tissue plasma levels were low and consistent with 
acidic moieties that are highly protein-bound. Similar levels of 
oxoacetic acid (6%) were excreted in the urine for both man and monkey 
(Borondy and Michniewicz, 1984).
Piroxicam was used as a positive control in comparative pharma­
cokinetic studies in the rat and cynomolgus monkey with the 2,4- 
difluoro derivative of N-(6-phenoxyindan-5-yl)methansulphonamide 
DF-PMS (Krause et al, 1983).
CGP 13 214D is also an oxicam (Fig.52). It was slowly absorbed 
following oral dosing and showd a plasma half-life of 26 hours in 
baboons thereby resulting in a higher systemic exposure to the un­
changed compound.
PIR0X1CAM
Figure 51: Proposed biotransformation pathway for piroxicam in the
rhesus monkey, other species are not shown (Hobbs and Twomey, 1981)
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Figure 52; Chemical structure of CGP 13 214D sodium salt
Diclofenac sodium (Voltaren®, Ciba-Geigy) with the structure 
(0-[2 ,6-dichloro-phenyl-amino] phenylacetic acid sodium salt) is 
extensively metabolised by man as well as baboon, dog and rat 
(Stierlin et al, 1979). Hydroxylated metabolites were the main forms 
found in the urine of both man and baboon, accounting for 60% to 70% of 
the dose respectively (Fig.53). Further studies showed biotrans­
formation in the rhesus monkey and baboon to be very similar.
Following single intramuscular administration of 1 mg/kg, urine 
recovery levels were 74% and 71% for rhesus and baboon respectively, 
and the same metabolites were present in both species (Stierlin and 
Faigle, 1979).
Pirprofen (Rengasil® Ciba-Geigy), dl-2[3-chloro-4-(3)pyrrolinyl) 
phenyl] proprionic acid, is metabolised by a combination of oxidation, 
ring-scission and glucuronic acid conjugation (Fig.54). There is 
extensive conjugation with glucuronic acid in the rhesus monkey and 
also in man (Egger et al, 1982). The drug was well absorbed in meta­
bolic studies and urinary excretion ranged from 75%-95% of the dose.
The related proprionic acid derivative suprofen, (RS)-2-(4-(2- 
thienylcarbonyl)phenyl)proprionic acid, is similarly metabolised and 
further, the plasma levels and pharmacokinetics in the monkey were 
comparable to man (Fig.55). Accordingly it would be expected that the 
monkey provides a better model for investigating the pharmacokinetics 
of suprofen for comparison with man (Mori et al, 1985).
In contrast to the predominantly urinary excretion of these 
compounds, the excretory route of fendosal (Alnovin®, Hoechst), 5- 
(4,5-dihydro-2-phenylbenz[e]indol-3-yl)salicylic acid, a compound based
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essentially in the salicylic acid group, was in the faeces. Unchanged 
fendosal and both a free and glucuronated form of monohydroxylated 
metabolite were identified, plus a small amount of dihydroxylated form 
in both man and rhesus monkey (Warrander et al, 1981), (Fig.56).
The metabolic processes and pathways available within different 
species of laboratory animals and man are important in activating 
prodrugs and forming various metabolites. The types and proportions of 
these, in turn, together with the specific excretory routes can clearly 
influence the target organ toxicity of each compound. Such species 
variation was amply demonstrated in metabolic studies of a substituted 
cinnamate ester anti-inflammatory prodrug (Ro 03-6037, Roche), ethyl- 
trans-B-methyl-4-(l-methyl-2-propynloxy)cinnamate. A variety of 
species including rat, mouse, baboon, marmoset, dog, rabbit and man 
were used, and all of them were capable of reducing the cinnamate 
double bond. But neither baboon nor man were able to complete the 
metabolic sequence requiring the removal of a one-carbon fragment to 
form the active anti-inflammatory agent (Marten, Ruane, East and 
Malcolm, 1983), thus rendering the compound unsuitable as a drug in 
man.
Other studies with NSAIDs have investigated the effects of the 
compounds zomepirac sodium and indomethacin upon renal blood flow in 
anaesthetised rhesus monkeys (Moore, Noordewier, Hook, Yorsey and 
O ’Neill, 1981), and the effects of indomethacin and meclofenamate upon 
renal blood flow in unanaesthetised baboons (Swain, Heyndrickx, 
Boettcher and Vatner, 1975).
There are only a few published reports on toxicological studies 
with anti-inflammatory agents in nonhuman primates. They include a
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chronic two year oral study in rhesus monkeys with an experimental 
compound L 5418 [Dow Chemical Company] (Emerson, 1976), and two studies 
in baboons; a one month oral study and a six month oral study with 
cyclohexyl-4-chloro-3-phenyl-4-oxo-4-butyric acid, (bucloxic acid 
[804CB, Esfar®, Laboratoire Midy), (Mazu£, Vallee, Genet, Navarro and 
Brunaud, 1974) and a six month oral study with parsalmide, 2-propar- 
gyloxy-5-amino-N-butyl benzamide (Parsal® Midy), (MazueJ Berthe, Richer 
and Vallee, 1976) (Fig.57). No comments relating to renal pathology 
were made in the two year study and the results suggested a varied, 
dose dependant toxicity with individual responses to L 5418, (Emerson, 
1976). Similarly, no kidney pathology was found in the parsalmide 
study (Mazu£ et al, 1976). In one of the bucloxic acid studies kidney 
lesions were seen. In the one month study at doses of 1200, 600, 300 
or 150 mg/kg/day pale areas were seen on the kidney surface at necropsy 
at all dose levels and were shown to be dilated tubules with intersti­
tial lymphoid cellular infiltrates. In the six month study at doses of 
250, 100 or 40 mg/kg/day no kidney effects were found. The compound 
was generally considered to be well tolerated, rapidly biotransferred 
and excreted in the primate (Mazu& et al, 1974). Mefenamic acid given 
to monkeys at 600 mg/kg for 5 days per week for up to 103 weeks caused 
dilated collecting tubules, considered to be of uncertain significance 
and was accompanied by colon and stomach erosions. Similar but lesser 
lesions were reported at 400 mg/kg. With flufenamic acid 
pyelonephritic scars were described at 100 mg/kg with raised urea 
levels and haematological changes. Pyelonephritis was again found 
after 12 weeks of 100 or 50 mg/kg of meclofenamic acid with gastro­
intestinal changes (Kaump, 1966). No further references containing
o— CH2— C=CH
I
- C— NH— CH2— CHo— CH2— CH,
II
O
NH,
2 propargyloxy-5-amino-N-butyl-benzamide
Figure 57: Chemical structure of parsalmide (Mazue et al, 1976)
experimental nonhuman primate renal pathology can be found in the 
published literature on NSAIDs. This may reflect the tendency to 
concentrate on the rat as the primary species of laboratory animal for 
toxicological investigation.
There are several possible mechanisms to explain the lesions 
caused in the kidney following administration of NSAIDs, especially 
with the development of RPN. In order to place these hypotheses into 
perspective with respect to nephrotoxicity, especially RPN, it is 
necessary to describe some of the separate functions of the cortex and 
medulla. The major biochemical pathways in the cortex include vitamin 
D metabolism, fatty acid utilisation, gluconeogenesis, xenobiotic 
metabolism and catabolism of prostaglandins. The medullary pathways 
comprise prostaglandin synthesis, lipogenesis, glycosaminoglycans 
synthesis, glycolysis and xenobiotic cooxygenation (Bach and Bridges,
1984). These pathways clearly define the two regions of the kidney as 
having distinctly specific functions. The medulla contains tubular 
and duct structures, blood vessels, interstitium with cells and 
matrix, and papilla epithelium. It is the impaired integrity of these 
structures that leads ultimately to RPN. What is not known precisely, 
is the cell type whose initial malfunction leads the pathogenesis to 
ultimate RPN. The hypotheses suggested to explain the mechanisms of 
RPN are diverse and include the immunological effects of NSAIDs, 
perturbation of kidney intermediary metabolism, hypoxia and vasocon- 
struction, and the counter-current theory, but there is conflicting 
experimental evidence to support some of these (Bach and Bridges,
The effects of NSAIDs on both the cellular and humoral of the 
immune response may be ascribed to altered suppressor cell function, 
inhibition of monocyte collagenase release, or inhibition of 
neutrophil activation and migration (Goodwin, 1984). These changes have 
been linked with both RPN and also with tubulointerstitial nephritis 
(Davies, 1968, Linton, 1984). Several NSAIDs are known to afiect the 
immune system (Goodwin, 1984). Data from rheumatoid arthritis studies 
in man using piroxicam, indomethacin and carprofen have suggested signi­
ficant reductions in immunoglobulin can be achieved without affecting 
cell viability. Such effects can be reversed with low levels of prosta­
glandin E2 (Goodwin, 1984). Whilst baboons show lymphocytic infiltrates 
in many tissues including the kidneys, it is doubtful that an immuno­
logical basis for participation in RPN can be seriously considered.
Whilst some workers have shown depressed kidney cortical inter­
mediary metabolism following analgesic administration (see Bach and 
Bridges 1984, for full discussion), there is no data yet available 
which lends weight to similar alterations in the medulla participating 
in RPN.
Medullary ischaemia has long been held to be the significant 
change predisposing RPN. The medulla is particularly susceptible to 
hypoxia and it is suggested that prostaglandin synthesised within the 
medullary interstitium facilitates vasodilation as part of normal 
kidney function in this region. This is then countered by the 
inhibitory action of many NSAIDs, the normal medullary blood flow is 
disturbed and ischaemia follows. Microvascular changes in long-term
experimentally-induced paracetamol nephropathy in rats (Furman, Kundig 
and Lewin, 1981), as well as in humans following analgesic abuse 
(Abrahams, 1976), have been considered a result of such prolonged 
prostaglandin suppression. A reasonable counter argument can be made 
on the grounds that the vascular changes and prostaglandin alterations 
are too simple a combination to conveniently lead to RPN and technical 
limitations prevent the testing of the role of prostaglandin changes. 
Nevertheless RPN does follow altered blood flow in sickle-cell disease 
in man in which poor local perfusion of the inner medulla is 
exacerbated by the low oxygen-carrying capacity of the erythrocytes.
In severe cases of this disease vasa recta can be blocked by the 
’sickling* of red cells. Further weight to the ischaemic factor 
theory is given in cases of shock, septicaemia, diarrhoea and 
dehydration in human infants where RPN again follows greatly 
diminished blood flow (Stirling, 1958; Chrispin et al, 1970), and in 
several species of domesticated animal when similarly dehydrated and 
undergoing veterinary treatment with either NSAIDs or phenothiazine 
(Salisbury, 1969; Gunson, 1983; Faulkner, Erb and King, 1984).
Lesions in the vascular bundles of the papilla have been produced 
experimentally (Kincaid-Smith, Saker, McKenzie and Muirden, 1968; 
Molland, 1978) and compared with urothelial lesions in the renal 
pelvis, upper ureter and papilla in man, comprising capillary sclerosis 
and characterised by basement membrane thickening resulting from toxic 
damage to both epithelial and endothelial cells (Mihatsch, Hofer,
Gudet, Knlisli, Torhorst and Zollinger, 1983). Since basement membranes 
are selective filters and are synthesised by the cells resting upon 
tfyem (Kefalides, Alper and Clark, 1979), it follows that the
thickening implies serious cellular dysfunction. It does not seem to 
be part of an acute lesion yet it is impossible to firmly relate 
whether such changes are the cause or consequence of chronically- 
induced changes (Bach et al, 1983). Using a direct method of measuring 
blood flow in the vasa recta in the rat, signficant reductions of 
medullary blood flow have been noted following NSAIDs administration 
(Holliger, Lemley, Schmitt, Thomas, Robertson et al, 1983). All these 
data both experimental and clinical strongly suggest that impairment of 
medullary blood flow is a significant factor in the development of RPN 
in man and animals.
The support for counter-current concentration involvement in 
developing RPN, relying on increased chemical concentration from cortex 
to medulla is contradictory and insecurely based on single admini­
stration data. A high papilla tip concentration of an agent does not 
automatically predispose to RPN (Bach and Bridges, 1984). The hypo­
thesis also denies the impaired ability to concentrate urine which 
is one of the earliest developments in analgesic nephropathy in both 
man and animals (Nanra, 1980; Angervall, Lehmann and Bengtsson, 1964).
Experimental RPN has been produced by a range of techniques which 
include injections of human serum (Kroe and Klavius, 1965), feeding a 
fat free diet (Molland, 1982), by disturbing renal haemodynamics 
(Sheehan and Davis, 1959) or by administration of one of a vast range 
of chemicals (Bach and Bridges, 1982, 1984). Chemicals seen to be 
more specific in their papillotoxicity and do not usually cause a more 
generalised effect on the medulla (Bach and Hardy, 1985). Even though 
investigative techniques have developed over the years it is still 
accepted that RPN cannot be easily or specifically identified by any
methods other than histopathology (Hardy, 1970; Bach and Bridges, 1982). 
This was confirmed in this baboon study.
The reproducibility of experimental RPN also seems to be fraught 
with difficulty (Kaump, 1966; Bokelman, Bagdon, Mattis and Stonier,
1971; Rosner 1976; Bach and Bridges, 1982), and the potential toxicity 
of some individual analgesics is still uncertain (Bach and Hardy,
1985). A further complicating factor with NSAIDs is their tendency to 
cause significant lesions in tissues other than the kidney. This is 
important where this event necessitates unscheduled sacrifice. Com­
pounds with anti-prostaglandin behaviour often cause gastrointestinal 
lesions sufficiently severe to prevent the development of remarkable 
kidney changes (Emmerson, Gibson, Pierce and Todd, 1973). They can 
also cause gastrointestinal lesions resulting in fluid loss, a 
condition significant in promoting RPN. In this baboon study the 
animal which received 20 mg/kg piroxicam and which showed RPN was 
sacrificed before schedule. It also displayed gastrointestinal lesions 
as well as kidney changes.
The prostaglandins are unsaturated fatty acid compounds which 
are derived from 20-carbon essential fatty acids (Clive and Stoff,
1984). Although they may be found in many organs and tissues through­
out the body, they are active only locally at the site of synthesis, 
and have a short half-life. It is currently accepted that prosta­
glandins are not stored in any tissue, but are rather synthesised 
immediately before their release, in response to the release of arachi- 
donic acid from the phospholipid fraction of cell membranes (Levenson, 
Simmons and Brenner, 1982), (Fig.58). Those prostaglandins showing 
activity within renal tissue are derived from a tetraenoic unsaturated
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Figure 58: Prostaglandins and the kidney (Levenson et al, 1982)
Pathways for prostaglandin and thromboxane biosynthesis and metabolism. 
Release of arachidonic acid by phospholipase A2 is the rate limiting 
reaction in prostaglandin and thromboxane synthesis. Degredation 
proceeds by multiple enzymatic and spontaneous reactions.
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20-carbon fatty acid, arachidonic acid. The major active forms are 
from the dienoic series (ie, PGE2) although some trienoic and pentanoic 
analogues are made, they are insufficient to show significant bio­
logical effects in the kidney (Dusting, Moncada and Vane, 1979). The 
enzymatic release of arachidonic acid from cell membrane phospholipids 
by phospholipase A2 can be influenced by a variety of factors. Such 
factors include angiotensin II, vasopressin, bradykinin, mechanical 
trauma, ischaemia and catecholamines (McGiff, Terragno, Malik and 
Lonigro, 1972; Flower and Blackwell, 1976; Clive and Stoff, 1984). 
Molecular oxygen is added to arachidonic acid by the dual action of 
cyclooxygenase and peroxidase. This forms the endoperoxidase PGG2.
This is then converted into the endoperoxide PGH2 after liberating a 
free superoxide radical. It is at this point in the sequence that 
many NSAIDs act by inactivating cyclooxygenase ie, carboxylic acid 
NSAIDs such as aspirin, flumixin, naprox;en, meclofenamate (Lees and 
Higgins, 1987). The results are a decrease in prostaglandin synthesis, 
and in addition superoxide and hydroxyl free radical conversion is 
reduced. PGH2 can then form a variety of biologically active products by 
the action of thromboxin synthetase (TxA2), prostacyclin synthetase 
(PGI2) or isomerases (PGF2a, PGE2). A further conversion of PGE2 to 
PGF2a can take place by the action of 9-keto-reductase. Thip step can 
be enhanced by high sodium levels or inhibited by diuretics. PGE2 and 
PGF2or are produced mainly by the medulla interstitial cells and to a 
lesser extent in glomeruli and papillary collecting tubules. PGI2 is 
mainly produced in arteriolar endothelium and again to a lesser extent 
in glomeruli and papillary collecting tubules (Garella and Matarese,
1984). There is some uncertainty about TxA2, for although identified 
in glomeruli it is probably derived from circulating platelets (Dunn 
and Zambraski, 1980).
Prostaglandins themselves have diverse functions. They are 
involved in hormone release, contraction of smooth muscle, vasodilation, 
stimulation and depression of the central nervous system, aggregation 
and disaggregation of blood platelets, secretion in the gastro­
intestinal tract, and mediation of the inflammatory response (Moncada 
and Vane, 1978). Within the kidney they function in the modulation of 
renin release (Heinrich, 1981), tubular ion transport (Fine and 
Kirschenbaum, 1981), water metabolism (Gross and Schrier, 1981), and 
autoregulation of kidney blood flow and glomerular filtration 
(Lifschitz, 1981; Schnerman and Briggs, 1981), these are given more 
specifically in Table 16.
The relationship between NSAIDs, the arachidonic acid cascade 
and altered prostaglandin activity has been recently reviewed (Bach 
and Bridges, 1984). It has been the subject of considerable interest 
with the increasing development of techniques enabling prostaglandins 
to be measured in different body tissues and fluids. This has only 
served to highlight the complex interrelationships between prosta- 
landins and other physiological stimuli and systems within the body, 
all of which may exert an effect upon the circulation and in particular 
the renal circulation. Generally the normal actions of renal prosta­
glandins PGE2 and PGI2 are primarily those of vasodilation and the 
enhancement of sodium excretion, and to some extent they counter the 
action of ADH and promote renin release. TxA2 is commonly thought to 
exhibit some vasoconstrictor activity. The overall dynamic result is 
thus to encourage vasodilation, sodium excretion, water excretion and 
increased renal perfusion. Conversely, serious disturbances of the 
prostaglandin sythesis cascade by whatever specific means certain
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individual NSAIDs acted would have a serious effect upon renal function 
in a variety of ways (Figs.59,60).
In humans such effects have been caused by non-narcotic 
analgesics and nonsteroidal anti-inflammatory compounds and comprise 
acute interstitial nephritis, acute tubular necrosis, poor renal 
perfusion leading to kidney failure, acute glomerulitis or vasculitis, 
the nephrotic syndrome and RPN (Garella and Matarese, 1984; Linton,
1984; Carmichael and Shankel, 1985), (Figs.61,62).
It is important to consider that such changes have not been 
recorded in normal healthy human patients but rather in those to whom 
NSAIDs were administered in the face of incipient disease, or in cases 
of dosage abuse.
Although the mechanism for by which many NSAIDs and analgesics may 
cause RPN via the arachidonic acid cascade is now known to involve oxi­
dative activation and the generation of free radicals (Bach and Bridges, 
1984), all NSAIDs or analgesics do not follow the same pathway. Indo­
methacin and aspirin pursue a single step pathway binding to cyclooxy­
genase, but paracetamol follows a two step pathway involving the con­
version of PGG2 to PGH2 (Fig.58). Phenylbutazone has a marked inhibitory 
effect upon prostaglandin hydroperoxidase activity and results in RPN 
(Mizuno, Yamamoto and Lands, 1982). A variety of other NSAIDs in con­
trast do not inhibit this conversion of PGG2 to PGH2 and yet inhibit 
soya bean lipoxygenase and also cause experimental RPN. Such compounds 
include naproxen, indomethacin, phenylbutazone, meclofenamate, mefana- 
mate, antipyrine, aminopyrine, benoxaprofen, paracetamol, ketoprofen, 
aspirin and ibuprofen (Sircar, Schwender and Johnson, 1983). Thus the
VOLUME CONTRACTION
t ADRENERGIC NERVOUS SYSTEM t RENIN-ANGIOTENSIN SYSTEM
t NOREPINEPHRINE t ANGIOTENSIN II
< ------  N S A I D s --------->
RENAL PROSTAGLANDIN SYNTHESIS
-> <■ 
RENAL VASOCONSTRICTION
Figure 59: Mechanism how NSAIDs offset compensatory vasodilation 
response of kidney prostaglandins to vasoconstrictor
hormones (Clive and Stoff, 1984)
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B diminish renal blood flow and enhance tubular NaCl reabsorption;
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state and possibly by interfering with cellular intake of potassium.
Figure 60: Mechanisms how NSAIDs enhance the cellular response to anti
diuretic hormone and increase osmotic drive for water absorption
(Clive and Stoff, 1984)
1Figure 61: Human kidney with analgesic nephropathy 
(material supplied by Dr J. McClure)
Figure 62: Human kidney with phenacetin-related RPN 
(material supplied by Dr. J. McClure)
behaviour of certain compounds seems anomalous. In baboons both indo­
methacin and meclofenamate have been shown to significantly modify 
reactive hyperaemia in the kidney (Swain et al, 1975).
A series of NSAIDs were tested for cyclooxygenase inhibition in 
human patients with rheumatoid arthritis. The drugs used were piroxicam, 
diclofenac, sulindac and naproxen. They were tested for their effects 
upon serum thromboxane, gastric, renal and synovial PGE2. After dosing 
for one week renal prostaglandin synthesis was depressed as measured by 
urinary levels, by 70% for piroxicam (20 mg/day), 61% for diclofenac 
(150 mg/day) and 59% for naproxen (750 mg/day). Sulindac at 400 mg/day 
had no effect. The overall results on kidneys and other tissues in 
rheumatoid patients suggested that piroxicam, diclofenac and naproxen 
displayed a nonselective cyclooxgenase inhibition. Sulindac spared 
gastric and renal effects but effected platelets and synovial cyclo­
oxgenase. Such variation in patterns of inhibition could be responsible 
for the incidence, degree and combination of side effects sometimes 
encountered in these anti-inflammatory compounds (Ciabattoni, Porro, 
Caruso, Fumigalli, Pugliese and Patrono, 1984). It is thus the sparing 
of prostaglandin synthesis that places any experimental anti-inflam­
matory compound in a better position for tolerance in man. An example 
is nabumetone, 4-(6-methoxy-2-napthyl)-butan-2-one(BRL 14777,Beecham) 
which is non-acidic, only poorly inhibits prostaglandin synthetase and 
is remarkably free from irritable effects within the gastrointestinal 
tract (Haddock, Jeffery, Lloyd and Thawley, 1984).
The structures in the medulla consisting of tubules, blood 
vessels, matrix and covering epithelium are among the first to show 
degenerative changes in the early stages of RPN. Changes in the cells
of the interstitium, capillaries of the vasa recta and the loops of 
Henle are later followed by changes in the papillary collecting duct 
epithelium and ultimately the epithelium covering the papilla tip 
(Bach and Bridges, 1984). The physiological changes demonstrated by 
early loss of urine concentrating function are followed by several 
histologically detectable changes in the interstitium. These may 
variously include necrosis, oedema, inflammatory infiltrates, 
haemorrhage, hyperaemia, mineralisation and crystal deposition. This 
diversity of interstitial response confirms the important role played 
by the interstitium in the pathogenesis of RPN. Both acute and 
chronically-induced RPN in animals have shown changes indicating that 
the interstitial cells themselves are the first structures to show 
degeneration (Rosner, 1976; Bach and Bridges, 1985), and they 
are intimately involved in prostaglandin synthesis (Muirhead, Germain, 
Leach, Pitcock, Stephenson et al, 1972; Garella and Matarese, 1984). 
Available biochemical data strongly suggests that in addition to an 
active prostaglandin synthetase system they are also capable of lip­
oxygenase activity enabling them to metabolise appropriate compounds 
(Winokur and Morrison, 1981). The interstitial cells of man, rat and 
rhesus monkey are generally comparable in structure when examined by 
electron microscopy (Osvaldo and Latta, 1966; Bulger, Tisher, Myers 
and Trump, 1967; Lewis and Prentice, 1979). The three species all 
possess stellate interstitial cells with long cytoplasmic processes, 
and in addition to moderate numbers of mitochondria and rough endo­
plasmic reticulum the Golgi-apparatus was found to be particularly 
well developed. This has been related to a probable secretory role 
(Bulger and Trump, 1966). Lipid droplets were also present and actual
droplet release was observed in some of the cells in the rhesus monkey 
giving support to the secretory role (Lewis and Prentice, 1979).
Further evidence in support of this could be linked to the increase 
in droplet numbers in experimentally related hypertension in rats 
(Bohman and Maunsbach, 1969) as well as in spontaneously hypertensive 
rats (Limas, Limas, Ragan and Freis, 1976), and to the associated vaso­
depressor activity of droplets in rats (Bohman and Maunsbach, 1969). 
These data support the interrelated functions of prostaglandins and 
the renin angiotensin system in the regulation of renal blood flow.
The droplets are identified by histochemical techniques as a mixture 
of phospholipids and polyunsaturated fatty acids, and which are 
utilised in lipid peroxidation (Bojesen, 1974). It is suggested that 
an appropriate chemical insult such as a high level of NSAIDs or meta­
bolites could inititate and potentiate lipid peroxidation. This could 
in turn lead to exhaustion of the interstitial cell lipid reserves or 
more likely cause injury or necrosis of these cells. This would reduce 
synthesis of PGE2 and PGF2a. The inherent and poorly understood 
capacity of interstitial cells to regenerate would then allow degen­
erative processes to begin. Thus the first tangible histological 
evidence towards the development of RPN would be early interstitial 
change.
The loss of any interstitial matrix is also important in the 
development of frank RPN. It contains abundant proteoglycans (POG) and 
glycosaminoglycans (GOG) and these (in combination with the Tamm- 
Horsfall glyco-protein molecule lining the distal portion of the 
nephron) play important roles in the regulation of water. RPN has been 
noted in humans with circulatory disorders requiring medication with
diuretics after NSAID administration. RPN has also occurred in cattle, 
sheep and horses when dehydration or compromised water supply compli­
cated either veterinary treatment with NSAIDs or the anthelmintic drug 
phenothiazine (Salisbury, 1969; Gunson, 1983; Faulkner et al, 1984). 
Rats are also more susceptible to experimental RPN when dehydrated 
(Nanra and Kincaid-Smith, 1970). Clinically, RPN has been found in 
children with dehydration from gastroenteritis (Chrispin et al, 1970). 
Disturbed urine concentration mechanisms occur early in experimental 
RPN and the association with early changes in the interstitial POG and 
GOG was demonstrated histochemically in rats using 2-bromoethanamine 
(BEA) (Bach et al, 1983). Significant changes in medullary POG 
staining have been reported in human analgesic nephropathy material 
(Burry, Cross and Axelson, 1977). The desulphation changes indicated 
by loss of medullary sulphate, increase in urinary sulphate and 
changes in urinary POG molecules in acute chemically induced RPN (Bach 
and Bridges, 1982), may be ascribed to the pharmacological action of 
NSAIDs which in suppressing prostaglandin synthesis also affect the 
production of interstitial matrix. The association between the strong 
intensity of the interstitium and POG/GOG status should however be 
interpreted with caution, even though some examples of reduced staining 
intensity have been associated with RPN following aspirin, fat-free 
diet or BEA (Molland, 1978; Shimamura and Bonk, 1976). Artefact-free 
staining for subjective assessment of such a variable entity as colour 
intensity is extremely difficult, even using automatic staining equip­
ment. Objective assessment using quantitative microscopy would be 
equally uncertain. Even with the frank RPN seen in this study the 
interstitial staining was uniform in animals representative from all
groups including controls. Altered colour intensity occurred only 
in areas of RPN which were already clearly identified with normal 
staining techniques. This method of detection would seem to require 
further investigation in order to increase the sensitivity and confirm 
the association.
The renal lesions encountered in this particular toxicity study 
in baboons with two similar compound, piroxicam and CGP 13 214D, 
showed variations in type, incidence and severity. During the course 
of the study there were no haematological or clinical chemistry data 
that could have been specifically related to RPN although increased 
urea levels suggest the possibility of some renal changes. Urinanalysis 
evidence of haemoglobinuria was a firmer indication of a suspected 
renal lesion. Only at necropsy was evidence of kidney lesions 
confirmed. It was possible to identify minute dark areas at the 
papilla tip in some individual baboons with the naked eye, but not to 
be more specific about the lesion. More detail was displayed using a 
stereo dissection microscope upon slices after fixation. The outline 
of the papilla tip in kidneys from control animals could then be 
compared with those of treated animals and the RPN seen in those 
animals affected. It would have been an advantage to have used the 
dissection microscope and camera during necropsy procedures upon 
freshly prepared kidney slices. Not only would it have been possible 
to identify kidneys from the left and right side but also to obtain 
photographs to confirm macroscopic comments. Retrospective examination 
of the papilla in human postmortem material has also been used to some 
advantage (Abrahams, 1985).
Generally it was possible to define a perspective of renal 
lesion severity. The most severe lesion being RPN accompanied by 
various degrees of epithelial hyperplasia at the margins of the 
necrosis, a usually minimal interstitial papillitis and interstitial 
necrosis, and mineralisation. In one instance crystals were present, 
but they were also seen in other animals in the absence of RPN.
Papilla interstitial oedema was a less severe lesion, also accompanied 
by epithelial hyperplasia and sometimes by crystal deposition. Inter­
stitial hyperaemia and haemorrhage was again a less severe lesion, to­
gether with epithelial hyperplasia. The mildest papilla lesion was 
epithelial hyperplasia unaccompanied by other changes.
The deposition of calcium oxalate crystals in the interstitium 
being found both with RPN and without RPN emphasises the role of the 
interstitium in NSAID-related pathology. There are rare references to 
crystals in the published literature on NSAIDs. It is possible that 
they are not routinely looked for and only polarised light, infra-red, 
specific histochemistry or electronmicroscopic methods can confirm 
their presence in tissues, and indicate the component elements and 
their proportions. They have been seen in rats (Bach, personal communi­
cation) and in horses with RPN (Gunson, 1983). In the latter they were 
identified as a mixture of calcium oxalate and calcium phosphate.
Urine is a supersaturated solution and it has been suggested that the 
mechanism for the precipitation of crystals largely involves both the 
amount and pH of the urine. Alterations in pH may be due to excreted 
compound or metabolites of NSAIDs or in man to urinary tract infection.
If dehydration is present then the concentration of oxalate normally 
present in the urine rises and precipitation occurs. Crystals were
noted in such circumstances in horses (Gunson, 1983) but were not 
mentioned as being present in dehydrated or diarrhetic infants with RPN 
(Chrispin et al, 1970), nor in dehydrated rats with RPN (Nanra and 
Kincaid-Smith, 1970). Most NSAIDs are acids and excretion of acidic 
urine in excess of the solubility product of oxalate would also 
encourage crystal formation and precipitation. In a normal kidney the 
negatively charged mucopolysaccharides within the interstitium bind 
calcium out of solution. But if the interstitium is disturbed, as is 
possible in NSAID administration, then calcium is not only precipitated 
but also combines with oxalate and phosphate to form crystals. This is 
not a single factor process but involves the dynamic interaction of 
several factors. Dietary mineral intake, particularly unbalanced levels 
of calcium, magnesium and phosphate may be involved. Experimental 
studies in baboons using a nephrogenic diet have shown calcium-rich 
granular cells near the basement membrane of collecting ducts (du Bruyn 
and Liebenberg, 1976). It is unlikely that dietary intake of ascorbic 
acid is involved since long-term high-level administration in baboons 
failed to show oxalate crystals in the kidneys or urinary bladder 
(du Bruyn, de Klerk and Liebenberg, 1977). It is common practice for 
diets in toxicological studies to be consistently and accurately formu­
lated to provide a stable nutritional environment and thus avoid such 
influences in the interpretation of experimentally-induced lesions. In 
one instance of RPN the crystals were intimately related to areas of 
mineralisation which in turn were deposited in the interstitium. 
Dystrophic mineralisation is a common but nonspecific response to tissue 
damage. Citrate and pyrophosphate are inhibitors for calcium phosphate 
and calcium oxalate inititiation and glycosaminoglycans, citrate and
pyrophosphate inhibit aggregation (Fleisch, 1978). The disturbed POG 
and GOG in the interstitial matrix may explain in some part the presence 
of mineralised deposits in the larger sheet form and the more delicate 
deposits outlining tubules and vessels within the papilla interstitium.
A further contributory factor would be the loss of solute control 
following damage to loops of Henle. Endogenous excretion of calcium in 
man and monkeys is similar, and unlike that of rats and dogs (Wanner, 
Moor, Bronner, Pearson and Harris, 1956). Renal handling of sodium 
and calcium is intimately related. Exogenous PGE2 infusion in anaes­
thetised monkeys (Macaca fascicularis) caused a significant calciuretic 
response. Similarly human hypercalciuric patients also showed reduced 
urinary calcium excretion following flurbiprofen (Buck, Lote and Sampson, 
1983). The collecting ducts and juxtamedullary nephrons are both 
involved in calcium, phosphate and magnesium transport, and calcium 
wastage occurs in RPN in rats confirming the importance of papillary 
structures in calcium excretion (Sabatini, Mehta, Hayes, Kurtzman and 
Arruda, 1981). Calcification is sometimes seen at necropsy In human 
RPN and phosphate stones may also be present in the pelvis (Heptinstall,
1983) Microscopically the fine granules of calcium present in the 
basement membranes of affected loops of Henle in man resemble those 
encountered in this baboon study.
The presence of hyperaemic papilla vessels with interstitial 
haemorrhage at the base of the collecting ducts beneath the papilla tip 
epithelium indicated some impairment of those vessels. Two animals 
showing these changes histologically also showed haemaglobinuria during 
the course of the study. No definite cause can be suggested other than 
treatment-related hypostasis and subsequent anoxia. It might be
related to the pharmacological anti-prostaglandin action of the NSAID 
compound.
Epithelial hyperplasia was the most common change at the papilla 
tip and in the collecting ducts, and would seem to be a less specific 
response than frank RPN. It could be construed merely as a compen­
satory reparative process to the irritation caused by passage of acidic 
urine, and at most levels within the reserve capacity of baboon uro- 
thelium to increase the mitotic index in response to damage (Sharieff 
et al, 1980). Papillary collecting ducts are capable of significant 
urine aqidifcation (Buerkart and Martin, 1981). RPN may occur when the 
combination of interstitial degeneration and exceeded urothelial regen­
erative capacity coincide. Such hyperplasia has been reported in 
acute and chronic RPN in experimental studies and also in human 
analgesic nephropathy (Bach and Hardy, 1985). There is an association 
with carcinoma of the pelvis, ureter and bladder with RPN in man (Bach 
and Hardy, 1985). Urothelial atypia has been noted in the pelvic epi­
thelium of end-stage kidneys in man following analgesic abuse (Blohm& 
and Johansson, 1981), but normally there is a long period preceeding 
the development of such malignant change in man (Heptinstall, 1983).
No similar experimentally induced urinary tract neoplasia has been 
reported in nonhuman primates. Only one transitional cell hyperplasia 
of pelvic epithelium was noted in a recent review of nonhuman primate 
tumours (Jones and Casey, 1981). The absence of neoplasia in almost 
all animal models is most probably related to the length of studies 
which are primarily designed for toxicological changes rather than 
purely for carcinogenesis. This is certainly so in nonhuman primate 
studies. The life span of nonhuman primates is such that prolonged
administration of NSAIDs would cause other significant lesions long 
before urothelial malignancy developed* It is also not clear that 
such neoplastic change simply follows RPN, but results from a combi­
nation of several as yet uncertain factors. Recent experimental work 
in rats using a combination of nephrotoxic compounds has however, 
yielded evidence of upper urothelial neoplasia (Gregg and Bach, 
personal communication). It remains to be seen whether similar 
procedures could produce neoplasia in other species closer to man and 
allow a more accurate extrapolation of data.
Interstitial cortical changes of chronic inflammation are 
generally accepted as secondary to RPN. The incidence in this study 
was very low. Infiltrates were predominantly lymphocytic although in 
one case fewer lymphocytes and more leukocytes were present. The true 
acute interstitial nephritis as described in man (Heptinstall, 1983), 
includes oedema. This was not seen in this study. Fenoprofen and 
naproxen have been reported as causative agents in human patients with 
combined nephrotic syndrome and renal failure. Aciite interstitial 
nephritis in these cases was thought due to a T-cell mediated hyper- 
senstivity reaction (Finkelstein, Fraley, Stachura, Feldman, Gandy et 
al, 1982).
Non-narcotic analgesics available as over-the-counter products 
and nonsteroidal anti-inflammatory drugs generally available by 
prescription are among the most commonly administered drugs for the 
treatment of a wide range of clinical diseases in man (Clive and 
Stoff, 1984; Eknoyan, 1984). These include the numerous connective 
tissue diseases, both acute and chronic painful conditions, peri­
carditis, superficial thrombosis, Bartter’s syndrome and dysmenorrhoea 
(Carmichael and Shankel, 1985). Patent ductus arteriosus in infants
has also been treated with indomethacin (Garella and Matarese, 1984; 
Kincaid-Smith, 1986). NSAIDs are generally considered to be therapeuti­
cally effective and to show only a low risk of a severe adverse drug 
reaction (Bulpitt, 1986). In the early 1980's it was considered that 
in the USA alone, some 20 million to 40 million people may have had a 
potential therapeutic indication for such compounds (Wiseman, 1982), 
and this may have contributed to the significant numbers of new anti­
inflammatory drugs that have entered the pharmaceutical market during 
the past 15 years (Carmichael and Shankel, 1985). It is not 
surprising therefore, when considering the size of the actual and 
potential clinical user population that adverse reactions have been 
encountered. Such reactions have generally reflected the pharmaco­
logical behaviour shown by the majority of NSAIDs in disturbing prosta­
glandin synthesis primarily in the gastrointestinal tract and the 
kidneys. Even this has been beneficial to some degree in that much of 
current data and knowledge on prostaglandins and the associated 
compounds thromboxane and leukotrienes, are a result of the study of 
adverse reactions (Garella and Matarese, 1984). Nevertheless, in 
spite of the considerable amount of published data on prostaglandins 
there is yet some unproven and even controversial opinion concerning 
their specific actions. A range of NSAIDs have been reported as 
causing significant renal lesions in both experimental animals and man 
and although no list of compounds can ever be considered complete, 
some examples are given in Table 17. In normal healthy patients the 
effect of NSAIDs has produced some conflicting information (Cinotti,
1984). Slight alterations in renal blood flow (RBF) and glomerular 
filtration rate (GFR) have been noted and fluid retention has also
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occurred (Kincaid-Smith, 1986). These effects are however at insig­
nificant levels (Dunn, 1984). It is generally accepted that the most 
important adverse effect of NSAIDs in man is analgesic nephropathy, and 
that the worst examples of this condition are seen in patients who abuse 
the dosing regimen (Crowshaw, 1984). There has been extensive documen­
tation of analgesic abuse and published data clearly show significant 
variations in geographical distribution, severity and incidence (Lee,
1979; Kincaid-Smith, 1980; Robinson, Cotran, Derryberry, Diaz-Buxo,
Dunn et al, 1984; Eknoyan, 1984; Garella and Matarese, 1984;
Kincaid-Smith, 1986). The different countries involved include Australia, 
Sweden, Switzerland, Scotland and South Africa (Kincaid-Smith, 1986).
Such countries show a significant portion of the inhabitants taking 
analgesics regularly and there are pronounced variations between these 
countries and even between different regions within each country. In 
the United Kingdom about 5% of cases presented with end-stage renal 
failure (ESRF) can be related to analgesic abuse. In Australia this 
rises to 21% (Lee, 1979). In the United States it is about 2%.
Internal variations show Glasgow to be higher within the UK, and 
North Carolina to be higher within the USA (Murray, 1978; Robinson,
Cotran, Derryberry, Diaz-Buxo, Dunn et al, 1984).
The kidney has a limited range of functional changes in response 
to insult and the most common adverse effects of analgesics or NSAIDs 
in man are interstitial nephritis, papillary necrosis and renal 
failure. Although accurate figures are difficult to obtain, and even 
when available are equally difficult to compare with the consumer pop­
ulation in a valid and meaningful way. Adverse reactions are 
generally rare (Garella and Matarese, 1984; Bulpitt, 1986). But they
have been reported in human patients with a range of pre-existing 
diseases which include hepatic cirrhosis, congestive heart failure, 
hypertension, lupus nephritis, renal parenchymal disease and nephrotic 
syndrome. Other complicating factors are dehydration, medication with 
diuretics, arteriosclerosis and old age (Dunn, 1984; Kincaid-Smith, 
1986; Bulpitt, 1986; Patrono, 1986). In almost all of these conditions 
the pharmacological action of the particular NSAID of disturbing prosta 
glandin synthesis has displayed a 'knock-on' effect to the other physio 
logical systems eg, renin-angiotensin-aldosterone, and kallikrein, with 
which prostaglandins are continually and dynamically related. This in 
turn, has lead to renal lesions together with a probable exacerbation 
of the original disease condition.
The renal data derived from this baboon study have have shown 
that a spectrum of lesions can follow NSAID administration in a non­
human primate species. Such lesions are comparable both in sequence 
and type to those in analgesic and NSAID abuse in man, and chemically- 
induced RPN in other experimental animal models. However some dif­
ferences were noted. Overall the lesions in the baboon were less 
severe than in man. In man RPN is usually bilateral, in baboons in 
this study it was unilateral. In man and some experimental animals 
RPN affects a large area of the papilla, but in the baboon RPN it was 
decrete. Inflammatory infiltrates were not a significant component of 
RPN in the baboon, nor were they prominent in secondary changes in the 
renal cortex or in the pelvis associated with urinary tract infection. 
Crystals were seen in the baboon but have not been reported in man.
Animal models of NSAID-related renal pathology and in particular RPN 
have yielded important data for comparison and extrapolation to man.
They have shown that cortical changes are essentially secondary to 
changes in the medulla. They have also suggested that hypertension 
can also follow either damage to the medulla alone, or to a combination 
of damage in the medulla and cortex (Rosner, 1976; Bach and Bridges, 
1985). Some questions remain unanswered. Why are the cells of the 
medullary interstitium the first step in NSAID-related RPN; can it be 
more than their association with prostaglandin synthesis; why do they 
have such a poor regenerative capacity; why do species difference in 
susceptibility to RPN exist?
It remains to be seen whether improvements in non-invasive methods 
of detection such as urinary enzyme assays and increased knowledge of 
the functions of the different cell types in the kidney at the molecular 
levels will assist in earlier and more efficient identification of 
disturbed renal function, not only due to non-narcotic analgesics and 
non-steroidal anti-inflammatory drugs, but to any other compound with a 
nephrotoxic potential. Nor should other technological advances be 
overlooked. Intra-ureteral or cystoscopic use of fibre optic instruments 
in man may well be able to show early morphological changes at the 
papilla tip and thus improve on radiological detection of gross changes, 
nonspecific clinical signs, and biopsy material and thus remove the 
dependance for reliable diagnosis from postmortem examination. In this 
combination of improved detection methods the extrapolation of experi­
mental data could yield certain and improved benefit to the pathogenesis 
of some human renal disease.
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